Usually inert substances added to a prescription in order to provide suitable consistency to the dosage form. These include binders, matrix, base or diluent in pills, tablets, creams, salves, etc.
Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed)
Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use.
The preparation, mixing, and assembling of a drug. (From Remington, The Science and Practice of Pharmacy, 19th ed, p1814)
The application of scientific knowledge or technology to pharmacy and the pharmaceutical industry. It includes methods, techniques, and instrumentation in the manufacture, preparation, compounding, dispensing, packaging, and storing of drugs and other preparations used in diagnostic and determinative procedures, and in the treatment of patients.
Substances made up of an aggregation of small particles, as that obtained by grinding or trituration of a solid drug. In pharmacy it is a form in which substances are administered. (From Dorland, 28th ed)
Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect.
The chemical and physical integrity of a pharmaceutical product.
Method of tissue preparation in which the tissue specimen is frozen and then dehydrated at low temperature in a high vacuum. This method is also used for dehydrating pharmaceutical and food products.
The quality or state of being wettable or the degree to which something can be wet. This is also the ability of any solid surface to be wetted when in contact with a liquid whose surface tension is reduced so that the liquid spreads over the surface of the solid.
SURFACE-ACTIVE AGENTS that induce a dispersion of undissolved material throughout a liquid.
Substances which are of little or no therapeutic value, but are necessary in the manufacture, compounding, storage, etc., of pharmaceutical preparations or drug dosage forms. They include SOLVENTS, diluting agents, and suspending agents, and emulsifying agents. Also, ANTIOXIDANTS; PRESERVATIVES, PHARMACEUTICAL; COLORING AGENTS; FLAVORING AGENTS; VEHICLES; EXCIPIENTS; OINTMENT BASES.
A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations.
Dosage forms of a drug that act over a period of time by controlled-release processes or technology.
A complex mixture of PHOSPHOLIPIDS; GLYCOLIPIDS; and TRIGLYCERIDES; with substantial amounts of PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; and PHOSPHATIDYLINOSITOLS, which are sometimes loosely termed as 1,2-diacyl-3-phosphocholines. Lecithin is a component of the CELL MEMBRANE and commercially extracted from SOYBEANS and EGG YOLK. The emulsifying and surfactant properties are useful in FOOD ADDITIVES and for forming organogels (GELS).
The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
Methylester of cellulose. Methylcellulose is used as an emulsifying and suspending agent in cosmetics, pharmaceutics and the chemical industry. It is used therapeutically as a bulk laxative.
Relating to the size of solids.
Homogeneous liquid preparations that contain one or more chemical substances dissolved, i.e., molecularly dispersed, in a suitable solvent or mixture of mutually miscible solvents. For reasons of their ingredients, method of preparation, or use, they do not fall into another group of products.
Substances added to pharmaceutical preparations to protect them from chemical change or microbial action. They include ANTI-BACTERIAL AGENTS and antioxidants.
Technique whereby the weight of a sample can be followed over a period of time while its temperature is being changed (usually increased at a constant rate).
GLYCEROL esterified with a single acyl (FATTY ACIDS) chain.
The process of keeping pharmaceutical products in an appropriate location.
Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form.
A polyvinyl polymer of variable molecular weight; used as suspending and dispersing agent and vehicle for pharmaceuticals; also used as blood volume expander.
Removal of moisture from a substance (chemical, food, tissue, etc.).
Compounds that provide LUBRICATION between surfaces in order to reduce FRICTION.
Differential thermal analysis in which the sample compartment of the apparatus is a differential calorimeter, allowing an exact measure of the heat of transition independent of the specific heat, thermal conductivity, and other variables of the sample.
A plant genus of the family CYPERACEAE. SESQUITERPENES are found in some of the species.
A copolymer of polyethylene and polypropylene ether glycol. It is a non-ionic polyol surface-active agent used medically as a fecal softener and in cattle for prevention of bloat.
The mechanical property of material that determines its resistance to force. HARDNESS TESTS measure this property.
A device that delivers medication to the lungs in the form of a dry powder.
A measure of the amount of WATER VAPOR in the air.
Method of using a polycrystalline powder and Rietveld refinement (LEAST SQUARES ANALYSIS) of X-RAY DIFFRACTION or NEUTRON DIFFRACTION. It circumvents the difficulties of producing single large crystals.
A diuretic and renal diagnostic aid related to sorbitol. It has little significant energy value as it is largely eliminated from the body before any metabolism can take place. It can be used to treat oliguria associated with kidney failure or other manifestations of inadequate renal function and has been used for determination of glomerular filtration rate. Mannitol is also commonly used as a research tool in cell biological studies, usually to control osmolarity.
An aromatic perennial plant species that has been used to treat migraines, arthritis, and as a febrifuge. It contains TANNINS, volatile oils (OILS, ESSENTIAL), and sesquiterpene lactones, especially parthenolide.
Any of a group of polysaccharides of the general formula (C6-H10-O5)n, composed of a long-chain polymer of glucose in the form of amylose and amylopectin. It is the chief storage form of energy reserve (carbohydrates) in plants.
Colloids formed by the combination of two immiscible liquids such as oil and water. Lipid-in-water emulsions are usually liquid, like milk or lotion. Water-in-lipid emulsions tend to be creams. The formation of emulsions may be aided by amphiphatic molecules that surround one component of the system to form MICELLES.
A group of compounds that are derivatives of octadecanoic acid which is one of the most abundant fatty acids found in animal lipids. (Stedman, 25th ed)
Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers.
Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity.
Salts and esters of the 12-carbon saturated monocarboxylic acid--lauric acid.
A test to determine the relative hardness of a metal, mineral, or other material according to one of several scales, such as Brinell, Mohs, Rockwell, Vickers, or Shore. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
A plant genus of the family COMBRETACEAE. Members contain arjunin, an ellagitannin (TANNINS).
Hard or soft soluble containers used for the oral administration of medicine.
Substances added to foods and medicine to improve the quality of taste.
A cellulose derivative which is a beta-(1,4)-D-glucopyranose polymer. It is used as a bulk laxative and as an emulsifier and thickener in cosmetics and pharmaceuticals and as a stabilizer for reagents.
Deacetylated CHITIN, a linear polysaccharide of deacetylated beta-1,4-D-glucosamine. It is used in HYDROGEL and to treat WOUNDS.
Sorbitan mono-9-octadecanoate poly(oxy-1,2-ethanediyl) derivatives; complex mixtures of polyoxyethylene ethers used as emulsifiers or dispersing agents in pharmaceuticals.
Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS).
Tablets coated with material that delays release of the medication until after they leave the stomach. (Dorland, 28th ed)
A chlorinated hydrocarbon that has been used as an inhalation anesthetic and acts as a narcotic in high concentrations. Its primary use is as a solvent in manufacturing and food technology.
Insulin derivatives and preparations that are designed to induce a rapid HYPOGLYCEMIC EFFECT.
Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS.
The maximum stress a material subjected to a stretching load can withstand without tearing. (McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed, p2001)
A clear, colorless, viscous organic solvent and diluent used in pharmaceutical preparations.
The resistance that a gaseous or liquid system offers to flow when it is subjected to shear stress. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
A clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. The chemical formula is hydrogen oxide (H2O). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
A change of a substance from one form or state to another.
A phenethylamine that is an isomer of EPHEDRINE which has less central nervous system effects and usage is mainly for respiratory tract decongestion.
A disaccharide of GLUCOSE and GALACTOSE in human and cow milk. It is used in pharmacy for tablets, in medicine as a nutrient, and in industry.
A polyester used for absorbable sutures & surgical mesh, especially in ophthalmic surgery. 2-Hydroxy-propanoic acid polymer with polymerized hydroxyacetic acid, which forms 3,6-dimethyl-1,4-dioxane-dione polymer with 1,4-dioxane-2,5-dione copolymer of molecular weight about 80,000 daltons.
Flammable, amorphous, vegetable products of secretion or disintegration, usually formed in special cavities of plants. They are generally insoluble in water and soluble in alcohol, carbon tetrachloride, ether, or volatile oils. They are fusible and have a conchoidal fracture. They are the oxidation or polymerization products of the terpenes, and are mixtures of aromatic acids and esters. Most are soft and sticky, but harden after exposure to cold. (From Grant & Hackh's Chemical Dictionary, 5th ed & Dorland, 28th ed)
Condition of having pores or open spaces. This often refers to bones, bone implants, or bone cements, but can refer to the porous state of any solid substance.
A generic term for a variety of compounds that contain silicon, oxygen, and magnesium, and may contain hydrogen. Examples include TALC and some kinds of ASBESTOS.
The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action.
A colorless liquid with a sharp burning taste and slight odor. It is used as a local anesthetic and to reduce pain associated with LIDOCAINE injection. Also, it is used in the manufacture of other benzyl compounds, as a pharmaceutic aid, and in perfumery and flavoring.
The presence of organisms, or any foreign material that makes a drug preparation impure.
Administration of a soluble dosage form between the cheek and gingiva. It may involve direct application of a drug onto the buccal mucosa, as by painting or spraying.
The conformation, properties, reaction processes, and the properties of the reactions of carbon compounds.

Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4. (1/728)

1. The effect of IL-4 on responses to intraplantar (i.pl.) carrageenin, bradykinin, TNFalpha, IL-1beta, IL-8 and PGE2 was investigated in a model of mechanical hyperalgesia in rats. Also, the cellular source of the IL-4 was investigated. 2. IL-4, 30 min before the stimulus, inhibited responses to carrageenin, bradykinin, and TNFalpha, but not responses to IL-1beta, IL-8 and PGE2. 3. IL-4, 2 h before the injection of IL-1beta, did not affect the response to IL-1beta, whereas IL-4, 12 or 12+2 h before the IL-1beta, inhibited the hyperalgesia (-30%, -74%, respectively). 4. In murine peritoneal macrophages, murine IL-4 for 2 h before stimulation with LPS, inhibited (-40%) the production of IL-1beta but not PGE2. Murine IL-4 (for 16 h before stimulation with LPS) inhibited LPS-stimulated PGE2 but not IL-1beta. 5. Anti-murine IL-4 antibodies potentiated responses to carrageenin, bradykinin and TNFalpha, but not IL-1beta and IL-8, as well as responses to bradykinin in athymic rats but not in rats depleted of mast cells with compound 40/80. 6. These data suggest that IL-4 released by mast cells limits inflammatory hyperalgesia. During the early phase of the inflammatory response the mode of action of the IL-4 appears to be inhibition of the production TNFalpha, IL-1beta and IL-8. In the later phase of the response, in addition to inhibiting the production of pro-inflammatory cytokines, IL-4 also may inhibit the release of PGs.  (+info)

The effects of inflammation and inflammatory mediators on nociceptive behaviour induced by ATP analogues in the rat. (2/728)

1. We have studied the behavioural effects of intraplantar injections of adenosine 5'-triphosphate (ATP) and related compounds in freely moving rats and investigated whether these nociceptive effects are augmented in the presence of inflammatory mediators. 2. We find that in normal animals ATP and analogues produce dose-dependent nocifensive behaviour (seen as bursts of elevation of the treated hindpaw), and localized thermal hyperalgesia. The rank order of potency was: alpha,beta-methyleneadenosine 5'-triphosphate (alpha,beta-methylene ATP) > 2-methylthioadenosine triphosphate (2-methylthio ATP) > ATP. After neonatal treatment with capsaicin, to destroy small calibre primary sensory neurones, nocifensive behaviour was largely absent. 3. The effects of ATP analogues were assessed in three models of peripheral sensitization: 2 h after dilute intraplantar carrageenan (0.25% w v(-1)); 24 h after irradiation of the hindpaw with ultraviolet (U.V.) B; immediately following prostaglandin E2 (PGE2) treatment. In all models the effect of alpha,beta-methylene ATP was greatly augmented. After carrageenan, significant hindpaw-lifting behaviour activity was induced by injection of only 0.05 nmol of alpha,beta-methylene ATP, some 100 times less than necessary in normal skin. 4. Our data suggest that it is much more likely that endogenous levels of ATP will reach levels capable of exciting nociceptors in inflamed versus normal skin. Our data also suggest the involvement of P2X3 receptor subunits in ATP-induced nociception.  (+info)

A study of local anaesthetics. Part 148. Influence of auxiliary substances on the surface tension, distribution coefficient and pharmaceutical availability from solutions of the potential drug VII. (3/728)

The influence of auxiliary substances of the polyol group (glycerol, propylene glycol, sorbitol) and of their concentration (5, 10, 15 and 20% by weight) upon surface tension, distribution coefficient and pharmaceutical availability from solutions of the potential drug VII, viz., N-[2-(2-propoxyphenylcarbamoyloxy)-ethyl] piperidinium chloride was studied. The substances were applied as hydrogel humectants. It was found that their influence on the surface tension, distribution coefficient and pharmaceutical availability from solutions of the potential drug VII depended on the type as well as concentration of the auxiliary substance. From the viewpoints of use in formulations of the drug form, sorbitol used at 5 and 10% concentrations represented the optimum.  (+info)

Beneficial effects of raxofelast (IRFI 016), a new hydrophilic vitamin E-like antioxidant, in carrageenan-induced pleurisy. (4/728)

1. Peroxynitrite is a strong oxidant that results from reaction between NO and superoxide. It has been recently proposed that peroxynitrite plays a pathogenetic role in inflammatory processes. Here we have investigated the therapeutic efficacy of raxofelast, a new hydrophilic vitamin E-like antioxidant agent, in rats subjected to carrageenan-induced pleurisy. 2. In vivo treatment with raxofelast (5, 10, 20 mg kg(-1) intraperitoneally 5 min before carrageenan) prevented in a dose dependent manner carrageenan-induced pleural exudation and polymorphonuclear migration in rats subjected to carrageenan-induced pleurisy. Lung myeloperoxidase (MPO) activity and malondialdehyde (MDA) levels, as well as histological organ injury were significantly reduced by raxofelast. 3. Immunohistochemical analysis for nitrotyrosine, a footprint of peroxynitrite, revealed a positive staining in lungs from carrageenan-treated rats. No positive nitrotyrosine staining was found in the lungs of the carrageenan-treated rats, which received raxofelast (20 mg kg 1) treatment. 4. Furthermore, in vivo raxofelast (5, 10, 20 mg kg(-1)) treatment significantly reduced peroxynitrite formation as measured by the oxidation of the fluorescent dihydrorhodamine 123, prevented the appearance of DNA damage, the decrease in mitochondrial respiration and partially restored the cellular level of NAD+ in ex vivo macrophages harvested from the pleural cavity of rats subjected to carrageenan-induced pleurisy. 5. In conclusion, our study demonstrates that raxofelast, a new hydrophilic vitamin E-like antioxidant agent, exerts multiple protective effects in carrageenan-induced acute inflammation.  (+info)

Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes. (5/728)

The relative cardiotoxicity of pegylated (STEALTH) liposomal doxorubicin (PL-DOX; Doxil) was compared to nonliposomal doxorubicin (Adriamycin) in rabbits and dogs treated i.v. for up to 22 weeks. No histological evidence of cardiotoxicity was seen in dogs treated with placebo liposomes or PL-DOX every 3 weeks for a total of 10 doses (cumulative doxorubicin dose = 10 mg/kg) either 1 or 5 weeks post-treatment. All dogs treated with the same cumulative dose of free doxorubicin showed marked cardiotoxicity (vacuolization and myofibrillar loss in the myocardium) at both time points. In rabbits, progressive cardiomyopathy was seen in both treatment groups, but was more frequent and severe with free doxorubicin (67% of doxorubicin-treated rabbits, cumulative dose = 12 to 14 mg/kg versus 16% of PL-DOX-treated animals, cumulative dose = 14 to 21 mg/kg). Five doxorubicin-treated rabbits died of congestive heart failure or with histologic evidence of cardiotoxicity (median severity score = 6). No PL-DOX-treated rabbits died of congestive heart failure, although two animals that died early showed microscopic evidence of mild cardiotoxicity (median severity score = 2.5). Cardiotoxicity increased during the post-treatment period in both treatment groups. Rabbits received up to 50% more PL-DOX with no increase in cardiotoxicity. Thus, results in two species demonstrate that the cardiotoxicity of doxorubicin is significantly decreased when administered as PL-DOX. Significantly more PL-DOX can be given without incurring an increased risk of cardiomyopathy. Recent clinical studies have confirmed that PL-DOX is also less cardiotoxic than the same dose of unencapsulated doxorubicin in humans.  (+info)

Enhancement of solubilization and biodegradation of polyaromatic hydrocarbons by the bioemulsifier alasan. (6/728)

Alasan, a high-molecular-weight bioemulsifier complex of an anionic polysaccharide and proteins that is produced by Acinetobacter radioresistens KA53 (S. Navon-Venezia, Z. Zosim, A. Gottlieb, R. Legmann, S. Carmeli, E. Z. Ron, and E. Rosenberg, Appl. Environ. Microbiol. 61:3240-3244, 1995), enhanced the aqueous solubility and biodegradation rates of polyaromatic hydrocarbons (PAHs). In the presence of 500 microg of alasan ml-1, the apparent aqueous solubilities of phenanthrene, fluoranthene, and pyrene were increased 6.6-, 25.7-, and 19.8-fold, respectively. Physicochemical characterization of the solubilization activity suggested that alasan solubilizes PAHs by a physical interaction, most likely of a hydrophobic nature, and that this interaction is slowly reversible. Moreover, the increase in apparent aqueous solubility of PAHs does not depend on the conformation of alasan and is not affected by the formation of multimolecular aggregates of alasan above its saturation concentration. The presence of alasan more than doubled the rate of [14C]fluoranthene mineralization and significantly increased the rate of [14C]phenanthrene mineralization by Sphingomonas paucimobilis EPA505. The results suggest that alasan-enhanced solubility of hydrophobic compounds has potential applications in bioremediation.  (+info)

Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord. (7/728)

Central sensitization, the hyperexcitability of spinal processing that often accompanies peripheral injury, is a major component of many persistent pain states. Here we report that the neurotrophin, brain-derived neurotrophic factor (BDNF), is a modulator of excitability within the spinal cord and contributes to the mechanism of central sensitization. BDNF, localized in primary sensory neuron cell bodies and central terminals, potentiates nociceptive spinal reflex responses in an in vitro spinal cord preparation and induces c-fos expression in dorsal horn neurons. NMDA receptor-mediated responses, known as a major contributor to central sensitization, were significantly enhanced by exogenous BDNF. Systemic NGF treatment, a procedure that mimics peripheral inflammatory states, raises BDNF levels in sensory neurons and increases nociceptive spinal reflex excitability. This increased central excitability is reduced by trkB-IgG, a BDNF "antagonist." We also show directly that inflammatory pain-related behavior depends on BDNF release in vivo. Thus behavioral nociceptive responses induced by intraplantar formalin and by intraplantar carageenan are significantly attenuated by trkB-IgG. Hence BDNF is appropriately localized and regulated in inflammatory states and is sufficient and necessary for the expression of central sensitization in the spinal cord. We propose that BDNF may function as a modulator of central sensitization in pathological states, and our results suggest that pharmacological antagonism of BDNF may prove an effective and novel analgesic strategy for the treatment of persistent inflammatory pain states.  (+info)

Carrageenan primes leukocytes to enhance lipopolysaccharide-induced tumor necrosis factor alpha production. (8/728)

We have previously reported that pretreatment with carrageenan (CAR) enhances lipopolysaccharide (LPS)-induced tumor necrosis factor alpha (TNF-alpha) production in and lethality for mice. Whole blood cultured in vitro was used to show that CAR pretreatment results in about a 200-fold increase in LPS-induced TNF-alpha production. CAR by itself did not induce TNF-alpha production. However, CAR-treated cultured medium sensitized whole blood to make more LPS-induced TNF than did saline-treated cultured medium in vitro. It was also demonstrated that CAR pretreatment increases TNF-alpha mRNA levels of both blood cells and peritoneal exudate cells, but not of bone marrow cells. Immunoelectron microscopic analysis revealed that polymorphonuclear leukocytes and macrophages are TNF-alpha-producing cells in CAR-treated mice. In CAR-treated mice, TNF-alpha was seen early after LPS injection in leukocytes in hepatic sinusoids and on the surfaces of endothelial cells. TNF-alpha was also detected late after LPS injection in hepatocytes which become edematous. These results suggest that CAR primes leukocytes to produce TNF-alpha in response to LPS and that they play an important role in the pathogenesis of liver injury.  (+info)

Although pharmaceutical excipients are considered pharmacologically inert, some excipients in dosage forms have shown an effect on the pharmacokinetics of certain drugs. This could be due to different mechanisms such as opening of tight junctions, inhibition of efflux transporters or interactions with the drug molecules. The presence of P-gp in the different regions of the gastrointestinal tract (GIT) is an important factor that may influence the absorption of drugs. Furthermore, the regions of the gastrointestinal tract have physiological differences that may have an impact on drug absorption, which is the reason why certain drugs have a limited absorption window after oral administration. The aim of this study was to investigate whether selected excipients, Ac-di-sol® (ADS) and Pharmacel® (PC), at different concentrations would have an effect on the transport of the model compound, Rhodamine 123 (Rho123), across excised sections of different regions from the pig gastrointestinal tract (i.e. ...
According to a latest market report published by Persistence Market Research, titled Global Market Study on Pharmaceutical Excipients: Increased Drug Demand in Emerging Asia Pacific Market to Fuel Demand Multi-Functional Excipients, revenue from the global pharmaceutical excipients market is expected to expand at a CAGR of 6.7% during the forecast period 2015 - 2021.. In the report, the global pharmaceutical excipients market is analyzed on the basis of chemistry type (i.e. source of origin), application type, functionality, and region. Based on chemistry type, the overall market has been segmented into plant-based, animal-based, mineral-based and synthetically derived excipients. Based on functionality, the market has been segmented into binders (binders, coatings, and fillers), glidents, diluents, disintegrants, and others (solvents, co-solvents, anti-microbial agents, lubricants, colorants, emulsifiers, and humectants). By application type, the market has been segmented into oral, topical, ...
There is a growing need for research into new skin- and environment-friendly surfactants. The aim of the study was to find out whether a combination of an alkylpolyglucoside natural surfactant with established pharmaceutical excipients could provide a solid pharmaceutical base with satisfied physical stability. The study was carried out in two phases: the first one focused on the colloidal structure of vehicles formulated with oils of different polarity and/or different costabilizer (lipophilic versus hydrophilic) and the second one evaluated vehicles physical stability. A number of techniques were used (polarization, light, and transmission electron microscopy, pH, conductivity and thermogravimetric measurements, rheological analysis and cyclic temperature stress test). Natural surfactants interaction with used excipients resulted in the formation of semisolid emulsion systems of different rheological profiles, stabilized predominantly by synergistic effects of lamellar liquid-cryst...alline ...
TY - JOUR. T1 - The effect of mucoadhesive excipient on the nasal retention time of and the antibody responses induced by an intranasal influenza vaccine. AU - Saito, Shinji. AU - Ainai, Akira. AU - Suzuki, Tadaki. AU - Harada, Norihiro. AU - Ami, Yasushi. AU - Yuki, Yoshikazu. AU - Takeyama, Haruko. AU - Kiyono, Hiroshi. AU - Tsukada, Hideo. AU - Hasegawa, Hideki. N1 - Funding Information: The work described in this report was supported by the grants of the Research Program on Emerging and Re-emerging Infectious Diseases (H25-Shinkou-Ippan-018) from the Japanese Ministry of Health, Labor, and Welfare. PY - 2016/2/24. Y1 - 2016/2/24. N2 - Introduction: Recently, we reported that intranasal vaccination of humans with whole inactivated influenza vaccine in the absence of mucosal adjuvant induced neutralizing antibody responses in the serum and nasal mucus. The mucoadhesive excipient carboxy-vinyl polymer (CVP) increases the viscosity and therefore mucoadhesiveness of intranasal medicaments and is ...
Webinar: Introducing the Co-processed Excipient Guide! Friday, December 15, 2017 - 11:00am to 12:00pm EST Featuring Joseph Zeleznik, Manager of Technical & Regulatory Affairs, Meggle USA, Inc., and Chair, IPEC-Americas QbD Committee Description IPEC-Americas and IPEC Europe have jointly published a guide for excipient makers and users on co-processed excipients. This guide offers best practice and voluntary guidance on the development, manufacture and use of co-processed excipients and provides support to both manufacturers and users of co-processed excipients. Webinar Objectives: ...
In order to develop the enhanced understanding necessary to demonstrate an acceptable Design Space and Control Strategy required for Quality by Design (QbD) marketing applications, it will be necessary to incorporate the variability in potentially critical excipient parameters into the Design of Experiments (DoE). Methods are described that allow samples to be engineered such that potentially critical excipient parameters can be included in the DoE. However, it must be acknowledged that not all such excipient parameters will be amenable to sample engineering. The excipient manufacturer may be able to provide non-GMP samples which help define the necessary limits for the formulation. The nature of QbD as it relates to excipients is such that communication under a confidentiality agreement between excipient users and excipient makers will be necessary. The necessity for good communication between the excipient user and manufacturer is also emphasized.. ...
Global Market Study on Pharmaceutical Excipients: Pharmaceutical excipients are substances other than pharmacologically active drug components, which are included in the drug manufacturing process or contained in a finished pharmaceutical product dosage form.
Data & statistics on Chinese Pharmaceutical Excipients: 1504 310 ความรูพื้นฐานทางเภสัชภัณฑ หนวยกิต 4 (3-3-6) Fundamentals to Pharmaceutical Dosage Forms สาขาเภสัชศาสตร ชั้นปที่ 3 จํานวน 107 คน อ.ดร.จินตนา นภาพร และ อ.ดร.วริษฎา ศิลาออน ทุกวันศุกร เวลา 08.00-16.00 น. ศึ ก ษาความรู พื้ น ฐานทางเภสั ช ภั ณ ฑ ใ นด า นคุ ณ สมบั ติ ท างกายภาพและเคมี (Physicochemical properties) ของสารที่เปนยาและสารชวยทางเภสัชกรรม (Pharmaceutical excipients) กฏทางฟสิกสเคมีและทฤษฎีที่เกี่ยวข
3. Why are excipients important in a drug product?For many reasons. Some, for example, comprise the products delivery system. These transport the active drug to the site in the body where the drug is intended to exert its action. Others will keep the drug from being released too early in the assimilation process in places where it could damage tender tissue and create gastric irritation or stomach upset. Others help the drug to disintegrate into particles small enough to reach the blood stream more quickly and still others protect the products stability so it will be at maximum effectiveness at time of use. In addition, some excipients are used to aid the identification of a drug product. Last, but not least, some excipients are used simply to make the product taste and look better. This improves patient compliance, especially in children. Although technically inactive from a therapeutic sense, pharmaceutical excipients are critical and essential components of a modern drug product. In many ...
The global pharmaceuticals excipients market is projected to post a phenomenal CAGR through 2022. The market is poised to rake in a healthy share of the revenue pie with robust growth of the pharmaceutical industry worldwide. Soaring uptake of oral and parenteral products owing to increasing occurrence of lifestyle and chronic disorders can escalate the growth of the market over the forecast period (2017 to 2022).. Browse Full Research Report With TOC On Pharmaceutical Excipients Market Size, Report, 2017 at: https://www.radiantinsights.com/research/global-pharmaceutical-excipients-market-professional-survey-report-2017. Emergence of novel therapeutics, especially in the form of oral dispersible tablets, is one of the key factors driving the market. Surging use of functional excipients is likely to provide an upthrust to the market. A raft of pharmaceutical companies is focusing on innovations in these excipient categories, which is expected to further bolster their use. Improving R&D ...
Global Active Pharmaceutical Ingredients (API) Market, By Molecule (Small Molecule, Large Molecule), Type (Innovative Active Pharmaceutical Ingredients, Generic Innovative Active Pharmaceutical Ingredients), Type of Manufacturer (Captive API Manufacturer, Merchant API Manufacturer), Synthesis (Synthetic Active Pharmaceutical Ingredients and Biotech Active Pharmaceutical Ingredients), Chemical Synthesis (Acetaminophen, Artemisinin, Saxagliptin, Sodium Chloride, Ibuprofen, Losartan Potassium, Enoxaparin Sodium, Rufinamide, Naproxen, Tamoxifen, Others), Type of Drug (Prescription Drugs, Over-the-Counter), Usage (Clinical, Research), Potency (Low-to-Moderate Potency Active Pharmaceutical Ingredients, Potent-to-Highly Potent Active Pharmaceutical Ingredient), Therapeutic Application (Cardiology, CNS & Neurology, Oncology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, Other Therapeutic Application), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain,
Alcohol excipients are inactive substances generally used as functional additives in pharmaceuticals. Excipient is inactive substance which is used with the active ingredients to improve absorption in body. Excipients also help to control the release of the active substances over a period of time if the treatment demands. As excipients are added to the formulations that contain active ingredients, they are also called bulking agents, fillers or diluents. They are also used to add flavor, and taste to certain pharmaceuticals.. Planning to lay down strategy for the next few years? Our report can help shape your plan better.. Alcohol excipients are also required to maintain the pH balance of the formulation, in order to optimize chemical stability and anti-microbial effectiveness. Some of the popular alcohol excipients include sorbitol, mannitol, propylene glycol, and glycerin among others. Excipients such as propylene glycol and glycerol are extensively used in aqueous suspensions and emulsions ...
These are just a few examples of many newer multifunctional or high-functioning excipients. Methods used to engineer these products include modification of particle size distribution by milling, seiving, agglomerating, spray drying, or roller compacting; selection of certain crystal polymorphic forms; cocrystallization, isolation of the crystal portion of the cellulose chain; modifications of the cooking process; modifications of the drying process; and nanosize water dispersion.2 Using multifunctional excipients simplifies the formulation process. Cost savings are not necessarily realized in reducing the amount of excipient used, which is a very small fraction of the cost of the tablet, but in reducing the total number of ingredients. Simple formulations are more straightforward to prepare, and fewer ingredients reduce the odds of adverse drug-excipient or excipient-excipient interactions. Multifunctional excipients are especially valuable in the manufacture of generic drugs, where there are ...
A microcrystalline cellulose-based excipient having improved compressibility, whether utilized in direct compression, dry granulation or wet granulation formulations, is disclosed. The excipient is an agglomerate of microcrystalline cellulose particles and from about 0.1% to about 20% silicon dioxide particles, by weight of the microcrystalline cellulose, wherein the microcrystalline cellulose and silicon dioxide are in intimate association with each other. The silicon dioxide utilized in the novel excipient has a particle size from about 1 nanometer to about 100 microns. Most preferably, the silicon dioxide is a grade of colloidal silicon dioxide.
SHREEJI PHARMA from Gujarat, India is a manufacturer, wholesaler, supplier of top quality pharmaceutical excipients at the best price.
Excipients are used in most drug products and the quality of the materials, manufacturing processes, and test methods are vital to the production of safe, effective therapies. While industry guidances, excipient monographs, and compendial test methods provide some direction, sourcing and testing of excipients is an ongoing challenge for drug manufacturers.. A complex supply chain, raw materials quality concerns, and lot-to-lot and supplier-to-supplier variability are just some of the factors that can affect the consistency of excipient quality and performance. Routine testing of excipients, therefore, is crucial. Drug manufacturers must not only verify compendial test methods, but also assess the suitability of these test methods to meet the requirements of excipients, manufacturing processes, and analytical instruments currently used.. In this webcast, experts will review measures drug manufacturers must take to comply with regulatory requirements; outline best practices for selecting and ...
The aim of study was for the development of any formulation, techniques such as thermal and isothermal stress testing were used to assess the compatibility of drug with excipients. Differential scanning calorimetry (DSC) and Fourier transformation infrared spectroscopy (FTIR) were the common methods for the study of compatibility. Isothermal stress testing (IST) is also a method for the compatibility study during proto type formulation. In the present study drug excipients compatibility study of gatifloxacin was conducted with different controlled release excipients. The drug and excipients mixtures were stored at 50°C for 4 weeks. The samples were then characterized using DSC, FTIR and UV spectrophotometric methods. The results show that gatifloxacin was compatible with the all the excipients used in the study. The excipients used in the present study were definitely incorporated in the extended release gatifloxacin formulation.
Manufacturer of Cellulose Derivatives and Excipients, Microcrystalline Cellulose, Sodium Starch Glycolate, Croscarmellose Sodium, Spirulina, Magnesium Stearate Etc.
AbeBooks.com: Handbook of Pharmaceutical Excipients (9780853693819) and a great selection of similar New, Used and Collectible Books available now at great prices.
As biotherapeutics are usually delivered by injection at relatively high concentrations, formulation viscosity is critically important, and a variety of small molecule excipients may be used to reduce viscosity by inhibiting protein aggregation, said Dr Leszczyszyn. Having the ability to screen formulations for viscosity issues or against a particular viscosity threshold at an early stage of development when sample volumes are limited, using a system such as the Viscosizer 200, will facilitate and expedite candidate selection and contribute to quicker, more cost-effective routes to market ...
For a detailed understanding of the market, the excipients market has been divided into overall excipients and oral solid-dosage-form (OSDF) The report comprises a detailed analysis and forecast of the excipients market on a global as well as regional level. On a global level, the forecast demand is based on volume (tons) and revenue (USD million) for the period ranging from 2012 to 2018. For an insightful understanding of the market on a regional level, the demand has been forecasted based on volume (tons) and revenue (USD million). The study consists of drivers and restraints of the excipients market and their impact on the growth of the market over the forecast period. In addition, the study takes into account opportunities available on a global and regional level and its effect on the market over the forecast period ...
The global excipients market size is expected to reach USD 6.9 billion by 2025, expanding at a CAGR of 6.02% from 2017 to 2025, according to a new report by Grand View Research, Inc. Globally increasing reach of generic medicines has been a major factor driving market growth. In addition, rising demand for newer excipients owing to the advantages of drug delivery and stability has led to the growth of the market. Excipients are essential components for the improvement of overall pharmaceutical activity and performance, both of which directly impact the characteristics of pharmaceutical formulations. An excipient in the right proportion can improve the shelf life and bioavailability of a formulation. These can also be used in drug delivery mechanisms such as sustained release and rapid release drugs.. Polymers were the largest product category in 2016 and are expected to maintain a comparatively moderate growth rate over the forecast period. Microcrystalline cellulose was the leading polymer in ...
An excipient is an inactive substance formulated alongside the active ingredient (API) of a medication, for the purpose of bulking-up formulations that contain potent active ingredients (thus often referred to as bulking agents, fillers, or diluents). Bulking up allows convenient and accurate dispensation of a drug substance when producing a dosage form. They also can serve various therapeutic-enhancing purposes, such as facilitating drug absorption or solubility, or other pharmacokinetic considerations.[1] Excipients can also be useful in the manufacturing process, to aid in the handling of the active substance concerned such as by facilitating powder flowability or non-stick properties, in addition to aidingin vitro stability such as prevention of denaturation over the expected shelf life. The selection of appropriate excipients also depends upon the route of administration and the dosage form, as well as the active ingredient and other factors. http://en.wikipedia.org/wiki/Excipient ...
Market Research Reports : Transparency Market Research published new market report Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market for Polymers (MCC, HPMC, CMC, Ethyl Cellulose, Povidone and Others), Alcohols (Glycerin, Sorbitol, Mannitol, Propylene Glycol), Minerals (Clay, Silicon Dioxide, Titanium Dioxide) and Sugars (Lactose, Sucrose) - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast, 2012 - 2018, the global OSDF excipients demand was 93.8 kilo tons in 2011 and is expected to reach 126.8 kilo tons in 2018, growing at a CAGR of 4.5% from 2012 to 2018. In terms of revenue, the market was valued at USD 570.6 million in 2011 and is expected to reach USD 869.1 million in 2018, growing at a CAGR of 6.3% from 2012 to 2018. The overall pharmaceutical excipients demand was 519.5 kilo tons in 2011 and is expected to reach 685.6 kilo tons in 2018, growing at a CAGR of 4.1% from 2012 to 2018. ...
Phospholipids have gained importance as formulation excipients due to their physicochemical diversity, biocompatibility, and capacity to enhance oral bioavailability of poorly water-soluble drugs.1)2) The main techniques for transforming liquid or semi-solid lipid formulations into solid-based particles or granules are spray-cooling, spray-drying, adsorption onto solid carriers, melt granulation, melt extrusion, supercritical fluid-based methods and high pressure homogenization.3) However, few studies have evaluated conventional dosage forms such as tablets containing phospholipids. Studies on incorporation of phospholipids into solid oral dosage forms such as tablets and pellets are rare.. Tableting involves several energy intensive processes, which could be a challenge for processing of phospholipids due to their waxy nature. Furthermore, powder properties such as the flowability and density of phospholipids and their blends with common excipients are important factors for their potential ...
China Pharmaceuticals Excipient Polyacrylic Resin II / III, Find details about China Polyacrylic Resin II / III, Pharmaceuticals Excipient from Pharmaceuticals Excipient Polyacrylic Resin II / III - Qingdao Jingtai Huacheng International Trade Co., Ltd.
excipient manufacturer/supplier, China excipient manufacturer & factory list, find qualified Chinese excipient manufacturers, suppliers, factories, exporters & wholesalers quickly on Made-in-China.com.
Mannitol is a pharmaceutical excipient that is receiving increased popularity in solid dosage forms. This study contributes to the development of mannitol as a potential excipient of the first choice.
Search PharmaCompass to Find Suppliers & Manufacturers of Polysorbate 80, Capsule Pharmaceutical Formulations for Co-Processed Excipients
A free-flowing directly compressible granulation useful as a slow release pharmaceutical excipient is disclosed. The excipient includes a hydrodrophilic matrix which includes a heteropolysaccharide and a polysaccharide material capable of cross-linking the heteropolysaccharide, and an inert diluent.
A free-flowing directly compressible granulation useful as a slow release pharmaceutical excipient is disclosed. The excipient includes a hydrodrophilic matrix which includes a heteropolysaccharide and a polysaccharide material capable of cross-linking the heteropolysaccharide, and an inert diluent.
The global excipients market is anticipated to reach USD 5.22 billion by 2020, growing at a CAGR of 6.0% from 2014 to 2020, according to a new report by Grand View Research, Inc. Growing developments in the field of medicine formulation and rise in research in the field of dosage technology are expected to drive this industry through the forecast period. Introduction of novel technologies for utilization of generic drugs in the development of new formulations is expected to boost growth of this industry over the forecast period. Furthermore, increasing global geriatric population base is anticipated to significantly raise demand for pharmaceuticals as this segment of the population is prone to high risk of organ disorders and infections, thereby propelling market growth.. Full research report on excipients market analysis: http://www.grandviewresearch.com/industry-analysis/excipients-market-analysis. Increasing demand for diverse excipients pertaining to interaction with active pharmaceutical ...
The global excipients market is anticipated to reach USD 5.22 billion by 2020, growing at a CAGR of 6.0% from 2014 to 2020, according to a new report by Grand View Research, Inc. Growing developments in the field of medicine formulation and rise in research in the field of dosage technology are expected to drive this industry through the forecast period. Introduction of novel technologies for utilization of generic drugs in the development of new formulations is expected to boost growth of this industry over the forecast period. Furthermore, increasing global geriatric population base is anticipated to significantly raise demand for pharmaceuticals as this segment of the population is prone to high risk of organ disorders and infections, thereby propelling market growth.. Full research report on excipients market analysis: http://www.grandviewresearch.com/industry-analysis/excipients-market-analysis. Increasing demand for diverse excipients pertaining to interaction with active pharmaceutical ...
The processibility of 15 carbohydrates, more or less commonly used, was investigated as excipients in supercritical fluid drying. The focus was on the ability to produce amorphous powder, the stability of the powders towards crystallisation, and the residual water and ethanol content. The aqueous solutions were sprayed into a pressurised carbon dioxide-ethanol mixture flowing cocurrently through a coaxial two-fluid nozzle. The powder characteristics appeared to be influenced by the supersaturation level reached during the SCF-drying process and by the properties of the sugar species, such as water solubility and glass transition temperature, or the solution viscosities. The stability and the residual solvent content of a selected set of sugars and some mixtures were further analysed. The stability of amorphous powders was investigated at 4 degrees C, room temperature, 40 and 50 degrees C. Lactose, maltose, trehalose, raffinose, cyclodextrin, low-molecular-weight dextran and inulin could form ...
Allcosmeticsource.com - Excipients- Anti-Agings,Amino Acids,Anti-Oxidants,Minerals,Memory Enhancement,Joint Health,Immune Support,Male Health,Miscellaneous,Herbal Extracts,Food Additives,Vitamins,Cosmetics,Weight Management,Excipients,Sports Nutrition,Sweeteners,Active Cosmetics Nature,Cardiovascular Health,Feed Additives,Phytochemicals,Active Ingredients,
Excipients in Pharmaceuticals Excipients in Pharmaceuticals The global excipients market should reach nearly $6.9 billion by 2020 from approximately $6.3 billion in - Market research report and industry analysis - 10039728
Granulocyte-colony stimulating factor (G-CSF) is a cytokine which is therapeutically used in oncology and hematology. It tends to form soluble and insoluble aggregates particularly under high-stress conditions that occur during the pharmaceutical production process. Aggregates of therapeutic proteins can cause severe adverse reactions after administration, but they also reduce shelf life and pharmacological activity. Prevention of protein aggregation in drug formulations is of considerable importance in pharmaceutical industry. Therefore high effort for optimization of formulations is necessary to obtain an optimum of protein stability. Knowledge about the mechanism and the process kinetics of G-CSF aggregation could enable the improvement of algorithms for the prediction of protein aggregation and lead to cost reduction of formulation development. The simulation of process conditions was accomplished by agitation and exposure of G-CSF to gas-liquid interfaces. Size exclusion HPLC was employed ...
The internal pore structure of chars derived from many bituminous and sub-bituminous coals can be best described by bi-modal pore size distribution. Their macropores, which account for nearly all the porosity, are interconnected spherical cavities with diameters as large 100 or 200 microns for 500--750 micron particles. Most of the internal surface area of these chars, however, is associated with micropores that are usually smaller than 30 A. In order to elucidate the effect of process conditions on the internal pore structure of coal-derived char particles and ultimately their overall reactivities, staged and sequential combustion algorithms are designed using thermogravimetric reactor equipped with in-situ video microscopy imaging (TGA/VMI). Our experiments showed that coal-derived char particles treated with higher pyrolysis heating rates have more open macropore structure than those treated with lower heating rates. At low combustion temperature where the reaction was kinetic controlled, the ...
The focus of this thesis was to evaluate the impact of mechanical activation (milling and dry mixing) and spray drying on the crystallinity of selected active pharmaceutical ingredients (APIs) and to explore the feasibility of co-processing these drugs with low glass transition temperature (Tg) excipients as a strategy for preventing process induced amorphisation. Co-milling investigations were initially performed on sulfadimidine and salbutamol sulphate. Based on the data obtained for these two APIs, further analysis was conducted on budesonide to see if results could be generalised to other compounds. Co-spray drying experiments were performed with sulfadimidine as API. The excipients chosen were dicarboxylic acids (glutaric, adipic, succinic, pimelic and malic acid) and sugar alcohols (mannitol and xylitol ...
Chemical APIs (Active Pharmaceutical Ingredients) Spectrum Chemical manufactures and distributes over 400 chemical APIs (active pharmaceutical ingredients. These substances are the biologically active component of any drug product regardless of pharmaceutical formulation type (tablets, capsules, topical, etc.). Spectru
(EMAILWIRE.COM, December 14, 2017 ) Europe Sugar based Excipients Market was worth USD 301.21 million in 2016 and estimated to be growing at a CAGR of 4.1%, to reach USD 368.23 million by 2021. A certain formulation contains both an active pharmaceutical ingredient and an excipient. It is mainly...
Author: Geiger Christine M, Sorenson Bridget, Whaley Paul, Year: 2015, Abstract: The stability of 10 active pharmaceutical ingredients was studied in SyrSpend SF PH4 or SyrSpend SF Alka at room and/or refrigerated temperature (2°C to 8°C). An oral suspension of each active pharmaceutical ingredient was compounded in low actinic plastic bottles at a specific concentration in SyrSpend SF PH4 or SyrSpend SF Alka. Samples were assessed for stability immediately after preparation (day 0) followed by storage at room temperature and/or at refrigerated temperature. At set time point
active pharmaceuticals ingredients manufacturer in india (API) , Wholesale ACTIVE PHARMACEUTICAL INGREDIENTS (API), Indian Manufacture, Indian Exporter, Indian Wholesaler, Indian Supplier, Indian Product
Further key findings from the report suggest:. • Crucial companies are, gradually more, concentrating on the vaccines; for example, Sanofi declared the investment of USD 601.37 million, for the research activities and the manufacturing of the vaccine in France. These funds are expected to impel the growth of novel vaccine active pharmaceutical ingredients, during the upcoming years, to assist in supply innovative products. • Consistent with the Centers for Disease Control and Prevention (CDC), roughly 795,000 people in the U.S., experience stroke each year. 87% of these cases are of ischemic stroke. • As per the information by World Health Organization (WHO), approximately, 17.5 million populace, expires every year, owing to the cardiovascular sickness, which is responsible for the 31% of the entire deaths, through the world. • The manufacturing companies require branching out their active pharmaceutical ingredients providers, to diverse places, rather than outsourcing it to merely one ...
Product Description Antidiabetic Active Pharmaceutical Ingredients Nateglinide CAS 105816-04-4 Product Name: Nateglinide Synonyms: (-)-n-(trans-4-isopropylcyclohexanecarbonyl)-d-phenylalanine;ay4166;Nateglinide(H);trans-d-phenylalanin;trans-n-((4-(1-methylethyl)cyclohexyl)carbonyl)-d-phenylalanine;3-phenyl-2-(4-propan-2-ylcyclohexyl)carbonylamino-propanoic acid;A-4166;STARLIX CAS: 105816-04-4 MF: C19H27NO3 MW: 317.42 Product Categories: Active Pharmaceutical Ingredients;API;APIs;Health & Beauty;Amino Acids & Derivatives;Intermediates & Fine Chemicals;Pharmaceuticals;Aromatics;STARLIX;Antidiabetic Melting point : 137-141°C Storage temp. : Room temp Chemical Properties : White Cyrstalline Solid Usage : antidiabetic KATP channel blocker…
SMi is delighted to announce its 2nd Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 21st - 22nd May 2018. http://www.highlypotentapi.com/phev. Conference Overview. The global market for Highly Potent Active Pharmaceutical Ingredients is currently largely driven by its major use in oncology for cancer treatment and more often in the form of ADCs. Over a quarter of drugs worldwide now contain HPAPIs, as they have proven to be more effective than other APIs. However, working with APIs high in potency and cytotoxicity comes with many regulations and requirements, and presents pharmaceutical companies with challenges such as handling, containment, cost and security questions.. This conference will cover many important and in-demand aspects of the HPAPI industry, creating a networking platform for industry professionals and key players to share their knowledge and find innovative new solutions.. This Years Speakers Include:. Chair for 2018:. Justin ...
Buy Top 99% Active Pharmaceutical Ingredients Formestane / Lentaron CAS 566-48-3 With Good Price from China- quality Active Pharmaceutical Ingredients for sale of realanabolicsteroids from China.
(EMAILWIRE.COM, November 24, 2017 ) In this report, the global Active Pharmaceutical Ingredients market is valued at USD XX million in 2017 and is projected to reach USD XX million by the end of 2021, growing at a CAGR of XX% during the period 2017 to 2021. Active Pharmaceutical Ingredients...
Pharmaceutical Technology has released an eBook called Solid Dosage and Excipients. The examines how advances in technology, equipment, excipients, analytical techniques, software, and manufacturing practices are facilitating the development, scale up, manufacturing, efficacy, and delivery of solid- and semi-solid dosage forms ...
Natural polysaccharides are drawing a great deal of attention in the recent years as excipient in the pharmaceutical industry. Due to the advances in drug delivery technology, natural polysaccharides are included in controlled drug delivery to fulfill multitask functions and in some cases directly or indirectly influence the extent and /or rate of drug release. In the present study, the polysaccharides extracted from Terminalia belarica gum (TBG) were evaluated for its safety and potency towards pre formulation studies as a pharmaceutical excipient. The study was undertaken with an objective to expound the physicochemical, thermal and functional properties of polysaccharide obtained from Terminalia belarica gum (TBG). A purified component of polysaccharide was isolated from Terminalia belarica gum (TBG) by gel filtration method. Elemental analysis, Scanning electron microscopy (SEM), X-ray diffraction spectroscopy (XRD), Differential scanning microscopy (DSC) and Fourier-transformed infrared ...
Market study report Global Solubility Enhancement Excipients for OSDF Market Insights Report 2019-2025 : BASF, Dow Chemical, Evonik, Shin-Etsu Chemicald Global Solubility Enhancement Excipients for OSDF Market 2019 Industry Research Report recently published on e-marketresearch.com is the key document for industries/clients to understand current global competitive market status. The Solubility Enhancement Excipients for OSDF market study report base year is 2018 and provides market research data status (2013-2017) and forecast (2019-2025) and also categorizes the Solubility Enhancement Excipients for OSDF market into key industries, region, type and application. Global Solubility Enhancement Excipients for OSDF Market 2019 study report covers all major geographical regions and sub-regions in the world and concentrates on product sales, value, market size and growth opportunities in these regions.. Competitive Analysis for Solubility Enhancement Excipients for OSDF market industries/clients :- ...
Cellulose acetate phthalate (CAP), a pharmaceutical excipient used for enteric film coating of capsules and tablets, was shown to inhibit infection by the human immunodeficiency virus type 1 (HIV-1) and several herpesviruses. CAP formulations inactivated HIV-1, herpesvirus types 1 (HSV-1) and 2 (HSV-2) and the major nonviral sexually transmitted disease (STD) pathogens and were effective in animal models for vaginal infection by HSV-2 and simian immunodeficiency virus. Enzyme-linked immunoassays and flow cytometry were used to demonstrate CAP binding to HIV-1 and to define the binding site on the virus envelope. 1) CAP binds to HIV-1 virus particles and to the envelope glycoprotein gp120; 2) this leads to blockade of the gp120 V3 loop and other gp120 sites resulting in diminished reactivity with HIV-1 coreceptors CXCR4 and CCR5; 3) CAP binding to HIV-1 virions impairs their infectivity; 4) these findings apply to both HIV-1 IIIB, an X4 virus, and HIV-1 BaL, an R5 virus. These results provide support for
TY - JOUR. T1 - Characterization of Grewia Gum, a potential pharmaceutical excipient. AU - Nep, Elijah I.. AU - Conway, Barbara R.. PY - 2010. Y1 - 2010. N2 - Grewia gum was extracted from the inner stem bark of Grewia mollis and characterized by several techniques such as gas chromatography (GC), gel permeation chromatography (GPC), scanning electron microscopy (SEM), differential scanning calorimetry (DSC) and thermogravimetric analysis of the extracted sample. Spectroscopic techniques such as x-ray photoelectron spectroscopy (XPS), fourier-transformed infrared (FT-IR), solid-state nuclear magnetic resonance (NMR), and 1H and 13C NMR techniques were also used to characterize the gum. The results showed that grewia gum is a typically amorphous polysaccharide gum containing glucose, rhamnose, galactose, arabinose and xylose as neutral sugars. It has an average molecular weight of 5925 kDa expressed as the pullulan equivalent. The gum slowly hydrated in water, dispersing and swelling to form a ...
Press Release issued Jul 18, 2017: Taste masking techniques are applied to overcome or mask the unpleasant and bitter taste of active pharmaceutical ingredients to achieve patient acceptability and compliance. Oral administration of bitter and unpleasant tasting drugs is often the biggest challenge for pediatric and geriatric patient groups. Unless the active ingredient is tasteless or does not have any unpleasant taste, taste-masking plays a key role in the success of a final solid oral dosage form. The efficiency of taste-masking is often a key determinant for the success of specialized dosage forms like orally disintegrating tablets and films, and chewable tablets. The mechanisms of taste-masking techniques often rely on two major approaches the first is to add excipients like sweeteners, flavors, and effervescent agents to mask the unpleasant taste, and the second is to avoid the contact of bitter and unpleasant drugs with taste buds.
ALBANY, New York, November 7, 2012 /PRNewswire/ --. According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) Excipients Market - Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth and Forecast, 2012 - 2018, the global excipients demand was worth USD 5,260.0 million in 2011 and is expected to reach USD 7,586.6 million in 2018, growing at a CAGR of 5.4% from 2013 to 2018. Currently, Europe dominates the global market in terms of demand; however Asia Pacific is expected to be the most promising market in the near future mainly due to the availability of low cost products and cheap labor. The North America market for excipients in terms of revenue is growing at a CAGR of 5.3% from 2013 to 2018 as the U.S. has the biggest pharmaceutical market globally.. Browse the full report at http://www.transparencymarketresearch.com/excipients-market.html. The demand for excipients is witnessing significant growth as it is ...
According to a new market report published by Transparency Market Research Excipients Market - Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth and Forecast, 2012 - 2018, the global excipients demand was worth USD 5,260.0 million in 2011 and is expected to reach USD 7,586.6 million in 2018, growing at a CAGR of 5.4% from 2013 to 2018. Currently, Europe dominates the global market in terms of demand; however Asia Pacific is expected to be the most promising market in the near future mainly due to the availability of low cost products and cheap labor. The North America market for excipients in terms of revenue is growing at a CAGR of 5.3% from 2013 to 2018 as the U.S. has the biggest pharmaceutical market globally ...
Marwaha, S.S.; Kennedy, J.F.; Sehgal, V.K., 1988: Simulation of process conditions of continuous ethanol fermentation of whey permeate using alginate entrapped Kluyveromyces marxianus NCYC 179 cells in a packed-bed reactor system
Contamination of bacteria in large-scale yeast fermentations is a serious problem and a threat to the development of successful biofuel production plants. Huge research efforts have been spent in order to solve this problem, but additional ways must still be found to keep bacterial contaminants from thriving in these environments. The aim of this project was to develop process conditions that would inhibit bacterial growth while giving yeast a competitive advantage. Lactic acid bacteria are usually considered to be the most common contaminants in industrial yeast fermentations. Our observations support this view but also suggest that acetic acid bacteria, although not so numerous, could be a much more problematic obstacle to overcome. Acetic acid bacteria showed a capacity to drastically reduce the viability of yeast. In addition, they consumed the previously formed ethanol. Lactic acid bacteria did not show this detrimental effect on yeast viability. It was possible to combat both types of bacteria by
Given the growing interest in the production of new and low cost bioemulsifiers, the rice and wheat bran and straw were investigated in this study for the production of bioemulsifier by Lactobacillus plantarum subsp. plantarum PTCC 1896 (probiotic). The strain produced bioemulsifier only in the rice bran hydrolysate medium. The bioemulsifier amount reached around 0.7 g L-1 for 72 hours of fermentation. The new biomolecule was extracted, purified, and its structural and thermal properties were evaluated. The functional groups and the structure of the molecule were revealed by GPC, FT-IR, 1HNMR and 13CNMR techniques. The bioemulsifier was a water soluble extracellular high molecular weight (|107 Da) α-glucan (81.74%) bound with protein (18.18%). Thermal behavior was studied using DSC and TG analysis. Thermal analysis showed the bioemulsifier broke down above 211.74°C, and the melting point was 182.0°C with the enthalpy value of 101.7 J g-1. These results might provide incentives for the industrial
Given the growing interest in the production of new and low cost bioemulsifiers, the rice and wheat bran and straw were investigated in this study for the production of bioemulsifier by Lactobacillus plantarum subsp. plantarum PTCC 1896 (probiotic). The strain produced bioemulsifier only in the rice bran hydrolysate medium. The bioemulsifier amount reached around 0.7 g L-1 for 72 hours of fermentation. The new biomolecule was extracted, purified, and its structural and thermal properties were evaluated. The functional groups and the structure of the molecule were revealed by GPC, FT-IR, 1HNMR and 13CNMR techniques. The bioemulsifier was a water soluble extracellular high molecular weight (|107 Da) α-glucan (81.74%) bound with protein (18.18%). Thermal behavior was studied using DSC and TG analysis. Thermal analysis showed the bioemulsifier broke down above 211.74°C, and the melting point was 182.0°C with the enthalpy value of 101.7 J g-1. These results might provide incentives for the industrial
Take advantage of the opportunity to present your company, your products and services to your target group with hardly any scattering losses.
The effect of the Active Pharmaceutical Ingredient (API) particle size on the dissolution rate in the polymer excipient during hot melt extrusion is investigated using a co-rotating twin-screw extruder with three different screw configurations. Acetaminophen (APAP) and amphiphilic polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer (PVCap-PVAc-PEG) (Soluplus) are chosen as the model API and water- soluble polymer excipient, respectively. APAP is milled using a fluid energy mill (FEM) into two different particle sizes. The thermal properties of processed samples are characterized by TGA and DSC. SEM and optical microscopy are also used in the morphological studies. Under quiescent conditions, API particles with small particle size dissolve faster than the large ones. During the extrusion process using a co-rotating twin- screw extruder, fully-filled kneading blocks perform well in dissolving the API into the polymeric excipient matrices for both of APIs particle sizes. However,
Selection of Optimal Hot Extrusion Process Parameters for AA6061-Fly Ash Composites: Using Simulation: 10.4018/IJMFMP.2018010104: The simulation of hot extrusion process is a challenging problem in process modeling because of very large deformations, strain rates and temperature changes
Driven by the rising demand for low-fat foods and the robust expansion of the global pharmaceutical excipient industry, the global microcrystalline cellulose market is expected to exhibit moderate growth over the period between 2014 and 2020. The report, titled Microcrystalline Cellulose Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020, states that the market will expand at a 5.80% CAGR over the reports forecast period and rise from a valuation of US$632.9 mn in 2013 to US$936.3 mn by 2020 ...
A therapeutic deep eutectic system (THEDES) is here defined as a deep eutectic solvent (DES) having an active pharmaceutical ingredient (API) as one of the components. In this work, THEDESs are proposed as enhanced transporters and delivery vehicles for bioactive molecules. THEDESs based on choline chloride (ChCl) or menthol conjugated with three different APIs, namely acetylsalicylic acid (AA), benzoic acid (BA) and phenylacetic acid (PA), were synthesized and characterized for thermal behaviour, structural features, dissolution rate and antibacterial activity. Differential scanning calorimetry and polarized optical microscopy showed that ChCl:PA (1:1), ChCl:AA (1:1), menthol:AA (3:1), menthol:BA (3:1), menthol:PA (2:1) and menthol:PA (3:1) were liquid at room temperature. Dissolution studies in PBS led to increased dissolution rates for the APIs when in the form of THEDES, compared to the API alone. The increase in dissolution rate was particularly noticeable for menthol-based THEDES. ...
TY - JOUR. T1 - The role of solid state characterization in predicting stability of solid dosage forms. AU - Szabó, Péter. AU - Zelkó, Romána. AU - Antal, István. PY - 2016/9/1. Y1 - 2016/9/1. N2 - Stability of a dosage form is its ability to preserve its quality attributes within preset limits. The time span over which these attributes remain within specifications is the shelf-life of the drug product. Stability is a very complex feature and is influenced not only by the stability of the drug substance but also by the stability of excipients and the interaction of the components within the system. Another important contributing factor is the packaging material, which is responsible for the protection of the drug product. Not only drug substances, but also excipients are susceptible to different degradation mechanisms. Amorphous polymers, a relatively frequently used group of excipients, are especially prone to physical instability. Through the process of physical ageing, a slow volume and ...
As all the three extruders are running at similar speeds, the end product is developed with minimal handling. A negative point of this process is the amount of production loss occurred, in case any of the three extruders is not running efficiently or there is some problem with only one of the extruders.. Wire coating is generally done by the use of single screw extruders, in which the crosshead extrusion process is carried out. The job of the extruder is to melt the resin & forward it to the die at an even & constant melt pressure and temperature. The crosshead extrusion process is carried out by using a general equipment in the line, which includes following basic pieces:. ...
Various techniques for physical characterization of active pharmaceutical ingredients, including X-ray powder diffraction, birefringence observation, Raman spectroscopy, and high-performance liquid chromatography, can be conducted using 96-well plates. to indicate the heat. The model medicines used were indomethacin (melting heat, 160C), mannitol (166C), carbamazepine (174C, … Emissivity of the samples is required to calculate absolute temps. That of the pharmaceutical powders was about 0.86 in most cases, and this value can be used at least for the testing purposes. Figure?5 shows the surface temps of indomethacin and carbamazepine determined using the infrared camera. In the case of indomethacin, before melting, the surface temperature of the samples improved at a heating rate identical to that of the sample plate, even though heat itself was lower than that of the surrounding plate. This was followed by a drastic increase in the sample temperature, caused by an increase in the thermal ...
Particle size effect on the performance of Active Pharmaceutical Ingredient,Technical Articles,Technology,Jinan Winner Particle Instruments Joint Stock Co. Ltd.,1) API market conditionoverview:the pharmaceutical industry is divided into the pharmaceu
Particle size effect on the performance of Active Pharmaceutical Ingredient,Technical Articles,Technology,Jinan Winner Particle Instruments Joint Stock Co. Ltd.,1) API market conditionoverview:the pharmaceutical industry is divided into the pharmaceu
Generic VERAPAMIL HYDROCHLORIDE availability. Has a generic version of VERAPAMIL HYDROCHLORIDE been approved? Find suppliers, manufacturers, and packagers
Quality Dietary Ingredients manufacturers & exporter - buy Levodopa,Carbidoba,Active pharmaceutical ingredient,White Powder from China manufacturer.
High quality C20H28O2 Active Pharmaceutical Ingredients Isotretinoin CAS 4759 48 2 from China, Chinas leading active pharma ingredients product, with strict quality control pharma raw material factories, producing high quality pharma raw material products.
Abstract. Thermal shift assays measure the stability of macromolecules and macromolecular assemblies as a function of temperature. The Particle Stability Thermal Release Assay (PaSTRy) of picornaviruses is based on probes becoming strongly fluorescent upon binding to hydrophobic patches of the protein capsid (e.g., SYPRO Orange) or to the viral RNA genome (e.g., SYTO-82) that become exposed upon heating virus particles. PaSTRy has been exploited for studying the stability of viral mutants, viral uncoating, and the effect of capsid-stabilizing compounds. While the results were usually robust, the thermal shift assay with SYPRO Orange is sensitive to surfactants and EDTA and failed at least to correctly report the effect of excipients on an inactivated poliovirus 3 vaccine. Furthermore, interactions between the probe and capsid-binding antivirals as well as mutual competition for binding sites cannot be excluded. To overcome these caveats, we assessed differential scanning fluorimetry with a ...
ACTIVE PHARMACEUTICAL INGREDIENTS (API) , Wholesale active pharmaceuticals ingredients manufacturer,(API), Indian Manufacture, Indian Exporter, Indian Wholesaler, Indian Supplier, Indian Product
Exporter of Active Pharmaceutical Ingredients - Ammonium Chloride Pure, Tannic Acid Powder, Silver Nitrate and Aluminium Sulphate Powder offered by S. V. Enterprises, Mumbai, Maharashtra.
One of the leading pharma companies india, API manufacturer in India offers more than 38 Active Pharmaceutical Ingredients manufacturers, nateglinide manufacturer in india, nebivolol manufacturers, nebivolol manufacturers, chlorhexidine gluconate manufacturer, pharmaceutical contract manufacturing companies in India and Drug Intermediates which are across the world
The Report Active Pharmaceutical Ingredients (API) Market in the Americas to 2017 - Shift Towards Generics and Biosimilars as South and Central America Emerges as a Key Growth Region provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz
V & V Pharma Industries, Exporter & Manufacturer Of Active Pharmaceutical Ingredients, APIs, Pharmaceutical Intermediates, Ninhydrin, Quinoline, Specialty Chemicals, Mumbai, India
Manufacturer of Active Pharmaceutical Ingredient - Ambroxol 30mg Levosalbutamol IMG Guiphenesin 50mg, VEGETABLE AND FRUIT WASH( SWASTH VEG), Prebiotics and Probiotics Explore Sachet and Levetiracetam -500 offered by Janaab(A Division of Arlak Biotech Private Limited), Zirakpur, Punjab.
[108 Pages Report] Check for Discount on United States High Potency Active Pharmaceutical Ingredients (HPAPI) Market Report 2017 report by QYResearch Group. In this report, the United States High Potency Active Pharmaceutical...
A comprehensive guide to side effects including common and rare side effects when taking Accupril (Quinapril Hydrochloride) includes uses, warnings, and drug interactions.
Accupril (quinapril hydrochloride) is an angiotensin-converting enzyme (ACE) inhibitor used to treat high blood pressure (hypertension) and heart failure.
A collection of nanoscale particles are a composite of carbon and metal oxide or silicon oxide. The composite particles have an average diameter from about 5 nm to about 1000 nm, and can be produced by laser pyrolysis. The laser pyrolysis involves the formation of a molecular stream including a metal precursor, an infrared absorber, an oxidizing agent and a carbon precursor. The pyrolysis is driven by heat absorbed from a laser beam. Furthermore, nanoparticles including titanium oxide with a rutile crystal structure have been produced.
0046] Pore formers 240 can be included in the mixture to enhance the pore space 120 of the bioactive scaffold 100. Pore formers are non-reactive materials that occupy volume in the plastic batch material during the mixing step 260 and the forming step 270. When used, the particle size and size distribution of the pore former 240 will influence the resulting pore size and pore size distribution of the pore space 120 of the scaffold 100. Particle sizes can typically range between about 25 μm or less to about 450 μm or more, or alternatively, the particle size for the pore former can be a function of the fibers 210 diameter ranging from about 0.1 to about 100 times the diameter of the fibers 210. The pore former 240 must be readily removable during the curing step 280 without significantly disrupting the relative position of the surrounding fibers 210. In an embodiment of the invention, the pore former 240 can be removed via pyrolysis or thermal degradation, or volatilization at elevated ...
The present invention relates to compositions comprising excipients or solubilizing agents for proteins. The invention relates to the discovery that a peptide derived from the N-terminus extension of the T266 isoform of rhBMP-2 has properties that enhance the solubility of proteins. The invention also relates to methods of resolubilizing a protein that has precipitated, by contacting the protein with a peptide comprised of the 17 amino acid extension of the T266 isoform of rhBMP-2. The invention also relates to methods of increasing the solubility of a protein by contacting the protein with a peptide comprised of the 17 amino acid extension of the T266 isoform of rhBMP-2.
We are an ISO 9001:2008 Certified Company Manufacturer, Supplier and Exporter of Excipients For Pharma And Cosmetic Cream based in Vadodara, Gujarat, India.
Founded in 1986, Signet Chemical Corporation Pvt. Ltd. is a pioneer in the excipients business in India.Since its inception, Signet has combined technical expertise with commercial support to provide its clients accurate information and exceptional product value. With 90 qualified and well-trained members, the Signet team has an excellent understanding of the intricacies of the market and has strong relationships with key partners to take the company forward.At Signet, the numbers speak for themselves.
The Isotope-Labeled Excipients Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with
Arginine was produced via fermentation of sugars using the engineered microorganism Escherichia coli. Zeolite-Y adsorbents in the form of powder and extrudates were used to recover arginine from both a real fermentation broth and aqueous model solutions. An adsorption isotherm was determined using model solutions and zeolite-Y powder. The saturation loading was determined to be 0.2 g/g using the Sips model. Arginine adsorbed from a real fermentation broth using either zeolite-Y powder or extrudates both showed a maximum loading of 0.15 g/g at pH 11. This adsorbed loading is very close to the corresponding value obtained from the model solution showing that under the experimental conditions the presence of additional components in the broth did not have a significant effect on the adsorption of arginine. Furthermore, a breakthrough curve was determined for extrudates using a 1 wt % arginine model solution. The selectivity for arginine over ammonia and alanine from the real fermentation broth at ...
MgSO4.7H2O 0.730 g/l) obtained by a Plackett-Burman Therefore, the objective of this research was to produce design and RSM were added, and the pH of the medium the finest-quality rice-based nutraceutical-containing maxi- was adjusted as per the experimental design with 0.1 M mum amount of a hypocholestromic agent (lovastatin). Two HCl or NaOH and autoclaved for 20 min at 121 °C. After filamentous fungi, M. purpureus MTCC 369 and M. ruber being cooled, the rice-based medium was inoculated with MTCC 1880, were used together as inocula for the mixed seed cultures of M. purpureus and M. ruber. Box- production of the nutraceutical under solid-state fermenta- Behnken response surface design (Sayyad et al. was tion. As the fermentation process is highly regulated by followed to design fermentation process conditions such as different fermentation process conditions, interactions of temperature, fermentation time, inoculum volume, and pH parameters and their optimum levels were determined by of the ...
There are multiple factors that drive glycosylation and several currently available approaches to influence glycosylation patterns. Notable factors that influence glycosylation include the following: cell culture process conditions, ingredients in cell culture, genetic selection or engineering, and directly impacting the physiological organelles responsible for glycosylation (endoplasmic reticulum - the ER - and Golgi apparatus). In cell line development there are opportunities to use genetic engineering tools to manipulate the glycosylation pathway. In upstream development, cell culture process conditions (ie. temperature and pH) can be manipulated. Lastly, commercially available constituents in the glycan process, such as precursors and enzymes, can be added to cell culture media to further hone glycoprofiles. However, there have been limited available approaches to improve the functionality of the ER and Golgi.. One relatively unexplored lever to improve ER and Golgi functionality, and thus ...
Shin-Etsu Chemical has been producing various cellulose derivatives. METOLOSE® is used for industrial (construction, personal care etc.) and food products. Others used as pharmaceutical excipients, such as coating agents and disintegrants.
Get Sample PDF of report at @ http://www.360marketupdates.com/enquiry/request-sample/10311263 After the basic information, the report sheds light on the production. Production plants, their capacities, global production and revenue are studied. Also, the Microcrystalline Cellulose(MCC) Market growth in various regions and R&D status are also covered.. Further in the report, the Microcrystalline Cellulose(MCC) Market is examined for price, cost and gross. These three points are analysed for types, companies and regions. In continuation with this data sale price is for various types, applications and region is also included. The Microcrystalline Cellulose(MCC) Industry consumption for major regions is given. Additionally, type wise and application wise consumption figures are also given.. Analysis also include consumption. Import and export data for Regions North America, Europe, China, Japan, Southeast Asia, India.. Purchase this report @ http://www.360marketupdates.com/purchase/10311263 With the ...
The effects of different formulations and manufacturing process conditions on the physical properties of a solid dosage form are of importance to the pharmaceutical industry. It is vital to have in-depth understanding of the material properties and governing parameters of its processes in response to different formulations. Understanding the mentioned aspects will allow tighter control of the process, leading to implementation of quality-by-design (QbD) practices. Computational intelligence (CI) offers an opportunity to create empirical models that can be used to describe the system and predict future outcomes in silico. CI models can help explore the behavior of input parameters, unlocking deeper understanding of the system. This research endeavor presents CI models to predict the porosity of tablets created by roll-compacted binary mixtures, which were milled and compacted under systematically varying conditions. CI models were created using tree-based methods, artificial neural networks ...
Ideally, the antibiotic would only act locally in the mouth rather than throughout the entire body. Mäders research group has therefore combined a proven antibiotic (minocycline) with an equally proven pharmaceutical excipient (magnesium stearate). The complex is just as effective, but more stable. It slowly releases the antibiotic on the spot, explains Mäder. In addition to the continuous and sustained release of the antibiotic, we needed to find an easy way of administering it. His research group found a practical solution to this problem by utilising pharma-grade polymers. The researchers were able to use these chemical substances to produce flexible, biodegradable rods containing the antibiotic. The small rods can be easily inserted into the gingival pocket. Since they are broken down by the body, they do not have to be removed after treatment. The rods are much more effective in vitro than previous products on the market, says Martin Kirchberg, who is studying the topic as part of ...
This third volume of the second edition offers information on specialized products such as emulsions, liposomes, polymers and polymeric pharmaceutical excipients. It explains the requirements for conducting clinical research and obtaining marketing approval for new drug products ...
... is a global organization founded in 1991 representing producers, suppliers, and ... IFPMA Weiner, Myra L.; Lois A. Kotkoskie (2000). Excipient toxicity and safety. Informa Health Care. p. iv. ISBN 978-0-8247- ... each of which focuses on local regulations concerning the excipients market, as well as on new research and business practices ... end users of excipients. The body has three divisions in Europe, Japan, and the United States, ...
"Vaccine Excipient & Media Summary" (PDF). Juan C. Ravell (January 11, 2021). "A Simple Breakdown of the Ingredients in the ... Excipient Vaccine types Vaccination schedule Adjuvant Preservative Cell culture Growth medium The initial list is based on ... This is a list of excipients per vaccine, as published by the United States Centers for Disease Control. Vaccine ingredients ...
... because absence of excipient cannot always be assumed not to be a variable. Such studies are called excipient-controlled or ... "Excipients: Background/Introduction". In Katdare A, Chaubal M (eds.). Excipient Development for Pharmaceutical, Biotechnology, ... Excipients can also be useful in the manufacturing process, to aid in the handling of the active substance concerns such as by ... An excipient is a substance formulated alongside the active ingredient of a medication, included for the purpose of long-term ...
The excipients can include diluents, binders or granulating agents, glidants (flow aids) and lubricants to ensure efficient ... It comprises a mixture of active substances and excipients, usually in powder form, pressed or compacted from a powder into a ... Some APIs may be tableted as pure substances, but this is rarely the case; most formulations include excipients. Normally, a ... Dry granulation requires drugs or excipients with cohesive properties, and a 'dry binder' may need to be added to the ...
R.S. Guad; S.J. Surana; G.S. Talele; S.G. Talele; S.B. Gokhale (2006). Natural Excipients. Pragati Books Pvt. Ltd. ISBN 978-81- ...
for polymeric excipients. In case of thiolated chitosan, for instance, a more than 10,000-fold increase in viscosity within a ... Laffleur, F; Bacher, L; Vanicek, S; Menzel, C; Muhammad, I (2016). "Next generation of buccadhesive excipient: Preactivated ... Bernkop-schnürch, A; Krauland, AH; Leitner, VM; Palmberger, T (2004). "Thiomers: potential excipients for non-invasive peptide ... "Development of pre-activated α-cyclodextrin as a mucoadhesive excipient for intra-vesical drug delivery". Int. J. Pharm. 534 (1 ...
ISBN 978-0-911910-28-5. Rowe RC (2009). "Aspartame". Handbook of Pharmaceutical Excipients. pp. 11-12. ISBN 978-1-58212-058-4 ...
International Pharmaceutical Excipients Council, 2010. Franck, A. (9 March 2007). "Technological functionality of inulin and ...
Rowe, Raymond (2009). Handbook of Pharmaceutical Excipients 6th Edition. London, UK: Pharmaceutical Press. pp. 56-58. ISBN 978- ... making it a useful excipient, but at the risk of causing damage to the surface of the eye. Laundry detergents and treatments. ... The use of appropriate excipients can also greatly enhance the spectrum, performance and detergency, and prevent deactivation ...
See also Excipient.) Diluents are also used in vaccines such as MMR to reconstitute the vaccine after storage. In underwater ...
"Macrogol as Excipient". Biesterfeld AG. Retrieved 10 June 2022. "PEG-3350 and Electrolytes for Oral Solution" (PDF). FDA. ... It is also used as an excipient. Side effects may include increased bowel gas, abdominal pain, and nausea. Rare but serious ... The doses of macrogol as an excipient are too low to have relevant contraindications. Allergy to macrogol is rare, and usually ... Macrogol is used as an excipient in pharmaceutical products. Lower-molecular-weight variants are used as solvents in oral ...
Excipient Spernath A; Aserin A (December 2006). "Microemulsions as carriers for drugs and nutraceuticals". Adv Colloid ... Heo MY; Piao ZZ; Kim TW; Cao QR; Kim A; Lee BJ (May 2005). "Effect of solubilizing and microemulsifying excipients in ...
Smolinske, Susan C (1992). Handbook of Food, Drug, and Cosmetic Excipients. CRC Press. pp. 75-76. ISBN 0-8493-3585-X. Golemanov ...
Smolinske SC (1992). Handbook of Food, Drug, and Cosmetic Excipients. p. 7. ISBN 0-8493-3585-X. Vivas N, Vivas de Gaulejac N, ...
Smolinske, Susan C. (1992). Handbook of Food, Drug, and Cosmetic Excipients. CRC Press. p. 347. ISBN 0-8493-3585-X. Yacoubou, ...
"Error" (PDF). Analytical Profiles of Drug Substances and Excipients. Academic Press. 19 March 2001. pp. 155-. ISBN 978-0-08- ...
Small amounts of oleic acid are used as an excipient in pharmaceuticals, and it is used as an emulsifying or solubilizing agent ... ISBN 978-84-613-4979-1. Smolinske, Susan C. (1992). Handbook of Food, Drug, and Cosmetic Excipients. pp. 247-8. ISBN 978-0-8493 ... Excipients, Insect pheromones, Insect ecology, Insect repellents, Alkenoic acids). ...
Brittain, Harry G.; McLeish, Michael J (20 Mar 1998). Analytical Profiles of Drug Substances and Excipients. Vol. 25. Academic ...
The primary excipients are established pharmacopoeial materials. Co-Processing Waste Materials in Cement Production On this ... Co-processing is a tool that is employed by pharmaceutical excipients manufacturers and formulation scientists to develop ... of the primary excipients. These modifications are reflected in the resulting coprocessed material as enhanced functionality. ... Rice husk Contaminated glass bottles Impregnated sludge Paint sludge Coprocessing is the combination of two or more excipients ...
Analytical Profiles of Drug Substances and Excipients. Vol. 29. pp. 261-320. doi:10.1016/S1075-6280(02)29009-6. ISBN ...
Analytical Profiles of Drug Substances and Excipients. Academic Press. 1992. p. 4. ISBN 9780080861159. Archived from the ...
ISBN 978-3-527-30247-5. Analytical Profiles of Drug Substances and Excipients. Academic Press. 20 March 1998. pp. 113-. ISBN ...
Asim, MH; Ijaz, M; Rösch, AC; Bernkop-Schnürch, A (2020). "Thiolated cyclodextrins: New perspectives for old excipients". ... Assim, HM; Ijaz, M; Rösch, AC; Bernkop-Schnürch, A (2020). "Thiolated cyclodextrins: New perspectives for old excipients". ... Development with Lipid Excipients 2017 Phoenix Science Award for Pharmacy 2022 He is author of over 500 research articles and ... A Potential Multifunctional Excipient for Ocular Drug Delivery". Int J Mol Sci. 23: 2612. doi:10.3390/ijms23052612. PMID ...
Al-Majed; Analytical Profiles of Drug Substances and Excipients. 2001, 162, 429-441. (Webarchive template wayback links, Liquid ...
Weiner, Myra L.; Kotkoskie, Lois A. (2000). Excipient Toxicity and Safety. New York: Dekker. p. 210. ISBN 978-0-8247-8210-8. ...
The pleasant taste and mouthfeel of mannitol also makes it a popular excipient for chewable tablets. Mannitol can be used to ... Weiner ML, Kotkoskie LA (1999). Excipient Toxicity and Safety. pp. 370. ISBN 9780824782108. Belcher R, Nutten AJ (1960). ... Excipients, Glycerols, Nephrotoxins, Osmotic diuretics, Wikipedia medicine articles ready to translate, Sugar alcohols, Sugar ...
In addition to its use in ophthalmic liquids, hypromellose has been used as an excipient in oral tablet and capsule ... Weiner, Myra L.; Lois A. Kotkoskie (1999). Excipient Toxicity and Safety. p. 8. ISBN 9780824782108. Reddy, Indra K.; Riz̤ā ... as well as an excipient and controlled-delivery component in oral medicaments, found in a variety of commercial products. As a ...
It is used as an excipient, and topical ophthalmic protectant and lubricant. HPC is an ether of cellulose in which some of the ... Weiner, Myra L.; Lois A. Kotkoskie (1999). Excipient Toxicity and Safety. p. 8. ISBN 978-0-8247-8210-8. Sanders, Joshua C.; ... Excipients, Cellulose, Cellulose ethers, E-number additives). ...
Weiner, Myra L.; Kotkoskie, Lois A. (1999). Excipient Toxicity and Safety. p. 10. ISBN 9780824782108. Demuth; et al. (2017). " ... Ritter, Steve (2008). "What's That Stuff? Excipients: Inactive ingredients in medicines serve multiple functions in drug ...
... is also present as an excipient in some pharmaceutical drugs. Dermatologists use acetone with alcohol for acne ... Weiner, Myra L.; Lois A. Kotkoskie (1999). Excipient Toxicity and Safety. p. 32. ISBN 978-0-8247-8210-8. Inactive Ingredient ... Excipients, Commodity chemicals, GABAA receptor positive allosteric modulators, Anticonvulsants). ...
Excipient selection strongly influences lyophilization performance for biologic drugs. ... "The selection of excipients is empirical, and pharmaceutical scientists first evaluate excipients that have a precedent in ... can help to predict or rule out various excipients or combinations of excipients, adds Thompson-Madsen. FDM enables the ... Using a novel excipient that has no precedent requires additional safety data and the cost and risk associated with this path ...
The diversity and variability of excipients and their fragmented supply chains allow for unknown risks to quality. Additionally ... as well as excipients, or the other ingredients that help the API do its work in the body. ... there are no harmonized approaches for regulating excipients for medicines. ... Because they comprise up to 90% of medications, the quality of excipients is critical for a drug to be safe and effective. Read ...
Joint FAO/WHO Expert Committee on Food Additives. Meeting (‎46th : 1996: Geneva, Switzerland)‎; World Health Organization; Food and Agriculture Organization of the United Nations; International Programme on Chemical Safety (‎World Health OrganizationWorld Health Organization, 1996)‎ ...
The present study is focused on the thermal decomposition of Levofloxacin in the absence and presence of different excipients ( ... DSC curves of Levofloxacin and Excipients alone and Levofloxacin with excipients; A-Levofloxacin, B-Sodium starch glycolate, C- ... Figure 5 exposes DSC curves of drug, excipient and drug-excipient mixtures. ... 5: DSC curves of Levofloxacin and Excipients alone and Levofloxacin with excipients; ...
The global sustained release excipients market size was valued at USD 1.19 billion in 2021 and is expected to grow at a ... Sustained Release Excipients Market Size Report, 2022-2030 GVR Report cover Sustained Release Excipients Market Size, Share & ... How big is the sustained release excipients market? b. The global sustained release excipients market size was estimated at USD ... What is the sustained release excipients market growth? b. The global sustained release excipients market is expected to grow ...
Excipient World is the leading education, networking and sourcing resource for the $6+ billion and growing global excipient ... Its the ONLY U.S. event focused exclusively on excipients and their vital role in the development, formulation, quality, ...
Factors for assessing excipient variability, the associated challenges developers need to address to design and manufacture ... www.pharmtech.com/excipient. ) in 2012. Participating in that webcast were Catherine Sheehan, director of excipients at the US ... Although excipients are required to meet the appropriate pharmacopeia standards, there may be differences in the excipient ... So one may ask, why are excipients variable, and what are the sources of variability? Well, excipients used within the ...
... the global revenues of the pharmaceutical excipients market are expected to grow at a CAGR of 5.8% in the coming years. ... Related tags: Excipients, Excipient, Generics, Small molecule drugs Bolstered by manufacturing advancements, the global ... Global pharmaceutical excipients market. Organic chemicals in high demand​. Among the segments of the pharmaceutical excipients ... In aggregate, excipients manufactured in oral formulations produced nearly 57% of the market revenues in 2019, at a total ...
Featured Excipient: Flavor Enhancing Agents. Allen Loyd V Jr Jan/Feb 2003. 48-50. Buy. ... Polysorbates, Featured Excipient:. Allen Loyd V Jr Mar/Apr 2002. 147-148. Buy. ... Featured Excipient: Plasticizers. Allen Loyd V Jr Mar/Apr 2003. 145-148. Buy. ... Wetting and/or Solubilizing Agents, Featured Excipient:. Allen Loyd V Jr Jul/Aug 2001. 310-312. Buy. ...
CordenPharma and Moderna extended a strategic manufacturing services agreement for the supply of lipid excipients to be used in ... CordenPharma and Moderna extended a strategic manufacturing services agreement for the supply of lipid excipients to be used in ... CordenPharma to Manufacture Lipid Excipients for Modernas Vaccine. .social-ris-container { display: flex; justify-content: ... extended their existing manufacturing agreement with Moderna to manufacture large-scale volumes of Modernas lipid excipients ...
This blog is about a recent publication on using Hansen Solubility Parameters to predict excipient impacts on drug packaging ... Besides the physical interactions between the excipients and silicone oil, the degradation of excipients due to the chemical ... how likely an excipient, or combination of excipients, will be to interact with (and potentially remove) a coating such as ... But what about the converse? How do we make sure that the drug, or more specifically its added excipients, does not affect the ...
The Nitrites in Excipients data sharing consortium was established in September 2020 and is part of Lhasa Limited's effort ... Nitrite analysis of excipients is a new and analytically challenging area, with many organisations working quickly to determine ... 79 excipients. Lhasa is enthusiastic and excited about the continuation and growth of the Nitrites in Excipients database, and ... the Nitrites in Excipients database allows members to gain a better understanding of the risk posed by excipients in the final ...
... a novel surfactant excipient able to more rapidly stabilise than conventional excipients. ... DuPont Nutrition & Health advancements in novel excipients recognised by pharmaceutical journal. 19-Dec-2018 ... The published paper, "Dynamic Properties of Novel Excipient Suggest Mechanism for Improved Performance in Liquid Stabilization ... The researchers found the excipient delivered improved performance in liquid stabilisation of protein biologics, providing a ...
The pharmaceutical excipients market is projected to reach USD 11.5 Billion by 2027 from USD 8.6 Billion in 2022, at a CAGR of ... FIGURE 10PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)70. FIGURE 11PHARMACEUTICAL EXCIPIENTS MARKET ... FIGURE 10PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)70. FIGURE 11PHARMACEUTICAL EXCIPIENTS MARKET ... FIGURE 7PHARMACEUTICAL EXCIPIENTS MARKET (SUPPLY SIDE): CAGR PROJECTIONS67. FIGURE 8PHARMACEUTICAL EXCIPIENTS MARKET (DEMAND- ...
... between 2023 to 2032.Pharmaceutical excipients are substances that are added to the active pharmaceutical ingredients (prodrug ... The global Pharmaceutical Excipients market size was estimated to be US$ 8.3 billion in 2021 and is expected grow at a CAGR of ... Regional performance of Pharmaceutical Excipients Market. Key sales and growth in the pharmaceutical excipient industry are ... The global Pharmaceutical Excipients market size was estimated to be US$ 8.3 billion in 2021 and is expected grow at a CAGR of ...
Global Biopharmaceutical Excipients Market Size Will Reach USD 3.07 Billion by 2026: Facts & Factors. * ... Global Biopharmaceutical Excipients Market Size Will Reach USD 3.07 Billion by 2026: Facts & Factors ...
Study at Kings College London with collaborators from Dubai Police and APDN concludes that DNA tagging excipients can mitigate ...
Exbumin is the only recombinant human serum albumin excipient available to improve viral stability for vaccines & gene ... Be the first to review "Exbumin® - Recombinant human albumin excipient" Cancel reply. You must be logged in to post a review. ... It is one of the few excipients available to improve viral stability for vaccines and gene therapies. Exbumin is also used to ... Exbumin has been approved for use as an excipient in injectable therapeutics by regulatory agencies. ...
Please note: Our products and services can only be used for research purposes. Do not use in diagnostic or therapeutic procedures ...
... a global leader in high-quality functional excipients for pharmaceuticals and nutraceuticals. ... DFE Pharmas excipients offer advantages such as high-cost efficiency, consistent high quality, and adaptability to meet the ... This new partnership allows Azelis to exclusively distribute the following DFE Pharma excipients: Nutracel®, Pharmacel® and ... Azelis announces distribution mandate for DFE Pharmas excipient solutions to EMEA countries. 31 October 2022 ...
View our infographic created to celebrate the launch of the ninth edition of the Handbook of Pharmaceutical Excipients. ... A brief history of excipients. Find out more about the emergence and development of excipients from their first use BC to the ... The worlds most authoritative source of information on excipients The Handbook of Pharmaceutical Excipients is the definitive ... Pharmaceutical Excipients provides information on the characteristics and physical properties of excipients, including side ...
Excipients, sometimes referred to as inactive or inert ingredients, are materials used every day in compounding and play a ... Describe excipient grades, types, and sources.. *Relate the role of excipients in stability, efficacy, and delivery of drugs in ... Describe excipient grades, types, and sources.. *Recognize the role of excipients in stability, efficacy, and delivery of drugs ... Identify fundamental excipients in compounded preparations.. *Select excipients based on functional role in a dosage form; ...
... - Ex*cip i*ent, a. [L. excipients, entis, p. pr. of exipere. See {Except}, v. t.] Taking an exception. [1913 Webster ... Excipient - An excipient is an inactive substance used as a carrier for the active ingredients of a medication. In many cases, ... Excipient - Un excipient désigne toute substance autre que le principe actif dans un médicament, un cosmétique ou un aliment. ... excipient - noun Etymology: Latin excipient , excipiens, present participle of excipere to take out, take up more at except ...
ESTHER] Probiotics Blue Premium No excipient Increase quantity for [DR. ESTHER] Probiotics Blue Premium No excipient ... ESTHER] Probiotics Blue Premium No excipient. [DR. ESTHER] Probiotics Blue Premium No excipient ... It is a pure, excipient-free product. (Free of silicon dioxide, magnesium stearate, synthetic flavoring, coloring, sweetener) ...
The Handbook of Pharmaceutical Excipients is the definitive summary of excipient specifications including pharmacopeial ... The worlds most authoritative source of information on excipients ... The worlds most authoritative source of information on excipients. The Handbook of Pharmaceutical Excipients is the definitive ... Pharmaceutical Excipients provides information on the characteristics and physical properties of excipients, including side ...
Please enter function of excipients, e.g. sweetener, preservative, thickening agent, etc. which can be selected from the drop- ... Please refer Appendix 8.2 List of Prohibited and Restricted Excipients; and Appendix 8.3 Lists of Permitted and Restricted ...
... play a significant role in the formulation and administration of dosage forms and the drug development process. They ... The word excipient, derived from the Latin phrase excipere - to receive, to except, or take out, refers to any component other ... Excipients and active ingredients form the major components of drugs. However, excipients make up the bulk of drugs and ... The word excipient, derived from the Latin phrase excipere - to receive, to except, or take out, refers to any component other ...
Sustained Release Excipients Market is projected to keep expanding over the forthcoming years; rise in the incidence of ... Sustained Release Excipients Market report explains a multitude of factors that have contributed towards market growth in ... and chronic diseases across the world has played a major role in the growth of the global sustained release excipients market ... Global Sustained Release Excipients Market: Overview. The demand within the global sustained release excipients market has been ...
  • View our infographic created to celebrate the launch of the ninth edition of the Handbook of Pharmaceutical Excipients. (medicinescomplete.com)
  • The Handbook of Pharmaceutical Excipients is the definitive summary of excipient specifications including pharmacopeial information and their regulatory status, providing you with a one stop resource when researching an excipient for use. (medicinescomplete.com)
  • In this webinar, recorded at the end of last year, the Pharmaceutical Press team are joined by the editors of the Handbook of Pharmaceutical Excipients to discuss the publication's history and plans for the future. (cphi-online.com)
  • This work highlights the importance of using fundamental science to understand pharmaceutical and pharmaceutical ingredient behaviour," said lead researcher Joshua Katz, PhD, Research Scientist, DuPont Pharma Excipients. (manufacturingchemist.com)
  • This new partnership allows Azelis to exclusively distribute the following DFE Pharma excipients: Nutracel ® , Pharmacel ® and Pharmacel ® sMCC90, high quality MCCs and co-processed MCC (microcrystalline cellulose) used as filler and binder in oral dosage forms. (azelis.com)
  • The concentration of other excipients in the formulation then occurs, which allows the large molecules to come sufficiently close to interact with one another," Sacha observes. (biopharminternational.com)
  • It's the ONLY U.S. event focused exclusively on excipients and their vital role in the development, formulation, quality, compliance and availability of drugs and consumer healthcare products. (ashland.com)
  • Excipients play a crucial role in a formulation, and as part of the formulation, influence the quality of the final drug product. (pharmtech.com)
  • The term excipient refers to any member of a broad group of surfactants, preservatives, tonicity agents, and buffers which formulation scientists take great care to balance in order to provide the drug, such as a therapeutic protein, in its most effective and deliverable state. (westpharma.com)
  • The ability to predict the interactions between excipients, and even the drugs themselves, and any component with which they come into contact, means that formulation and packaging scientists can more quickly narrow down what will or will not work for their drug. (westpharma.com)
  • In an investigation presented at the 2018 PDA Universe of Pre-Filled Syringes (Risk of Drug Formulation and Syringe / Autoinjector Functionality) it was demonstrated using HSP calculations, along with experimental methods such as contact angle and interfacial tension, that there was a correlation between observed inconsistencies observed in syringe glide forces and excipients that were predicted to have a higher likelihood to interact with silicone oil. (westpharma.com)
  • The information learned should provide insight to help understand the careful selection of specific excipients and address formulation challenges and opportunities. (lp3network.com)
  • Excipients play a significant role in the formulation and administration of dosage forms and the drug development process. (nvronhealthcare.com)
  • Beyond increasing the bulk of formulation and simplifying the manufacturing process, excipients perform a variety of roles such as binding ingredients, boosting patient's acceptance and compliance (by masking unpleasant odors or tastes), enhancing the stability of active ingredients, extending viability and acting as diluents (for example, microcrystalline cellulose, starch), etc. (nvronhealthcare.com)
  • Whilst excipients are the lower cost and less active part of any end use formulation, they play a vital role in delivery, storage and quality of pharmaceutical products. (sgs-latam.com)
  • Co-processed excipient has received much more attention in the formulation development of various dosage forms, specially for tablet preparation by direct compression method. (who.int)
  • Furthermore, it opens the opportunity for development and use of single multifunctional excipient rather than multiple excipients in the formulation. (who.int)
  • Drug products combine active pharmaceutical ingredients with excipients in a final formulation for delivery to patients in liquid or lyophilized (freeze-dried) packaged forms - with the latter requiring reconstitution in the clinical setting. (bioprocessintl.com)
  • The global sustained release excipients market size was valued at USD 1.19 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 8.22% from 2022 to 2030. (grandviewresearch.com)
  • The global Pharmaceutical Excipients market size was estimated to be US$ 8.3 billion in 2021 and is expected grow at a CAGR of 6.1% between 2023 to 2032 . (pharmiweb.com)
  • 150+ Pages Report] As per the latest Research and survey report issued by Precedence Research, the global pharmaceutical excipients market was valued at around USD 8.85 billion in 2021 and is expected to register revenues worth USD 14.2 billion by the end of 2030 , growing at an exceptional CAGR of approximately 5.39% between 2022 and 2030. (marketstatsnews.com)
  • 2021 Hubei Humanwell pharmaceutical excipients Co., Ltd. (humanwellcaps.com)
  • Using the principle that "like dissolves like", HSP calculations determine how "alike" two materials are, and by extension, how likely an excipient, or combination of excipients, will be to interact with (and potentially remove) a coating such as silicone oil. (westpharma.com)
  • Co-processing is a novel concept of combining two or more excipients that possess specific advantages that cannot be achieved using a physical admixture of the same combination of excipients. (who.int)
  • With advantages offered by the upcoming newer combination of excipients and newer methods of co-processing, co-processed excipients are for sure going to gain attraction both from academia and pharmaceutical industry. (who.int)
  • Moreover, evaluation of the potential of controlled release excipients for the manufacturing of the COVID-19 vaccine is continued. (grandviewresearch.com)
  • This is also due to "better assimilation of topical excipients with liquid APIs and increased patient compliance due to sensorial effects on the dermal layer," ​ M&M states. (outsourcing-pharma.com)
  • CordenPharma, a contract development and manufacturing organization (CDMO) for APIs, drug products, and pharmaceutical packaging, extended their existing manufacturing agreement with Moderna to manufacture large-scale volumes of Moderna's lipid excipients to be used in the manufacture of Moderna's vaccine candidate (mRNA-1273) against the novel coronavirus (SARS-CoV-2), the companies announced in a May 28, 2020 press release. (biopharminternational.com)
  • SIO HistorySIO's beginnings date back to 1907, and today, is one of the most important global pharmaceutical oil manufacturer.As a subsidiary of Archer Daniels Midland Company since 1996, our company manufactures state-of-the-art purified pharmaceutical oils that can be used as APIs or as excipients for oral, topical and injectable formulations of oil-soluble drugs. (ronpharm.com)
  • Our goal is to manufacture our supplements as pure as possible, so we don't use fillers, binders, or chemical excipients. (greenorganicsupplements.com)
  • The role of excipients is to ensure that this disruption is minimized," she says. (biopharminternational.com)
  • Recognize the role of excipients in stability, efficacy, and delivery of drugs. (lp3network.com)
  • Relate the role of excipients in stability, efficacy, and delivery of drugs in support of formula requirements. (lp3network.com)
  • Factors that are boosting the market's growth include technological advancements in functional and multifunctional excipients required for orphan drugs, which are being increasingly adopted. (outsourcing-pharma.com)
  • According to the report, this is also due to the rising demand for co-processed multifunctional excipients. (outsourcing-pharma.com)
  • The expanding usage of generic medications and increased demand for multifunctional excipients is expected to be the key contributors to growth and revenue in the pharmaceutical excipients market. (pharmiweb.com)
  • The present study is focused on the thermal decomposition of Levofloxacin in the absence and presence of different excipients (sodium starch glycolate, magnesium stearate, microcrystalline cellulose and lactose using Thermogravimetry (TG). (researchgate.net)
  • It has been shown that the interaction of the first three excipients (sodium starch glycolate, magnesium stearate, and microcrystalline cellulose) with Levofloxacin is physical in nature. (researchgate.net)
  • Excipients: water-soluble methylcellulose - 1 mg, magnesium stearate-1 mg. (russianfoods.com)
  • After Natural News revealed the complete list of vaccine excipient ingredients published by the CDC earlier this week, the vaccine-pushing mainstream media exploded with accusations that falsely claimed Natural News was writing "fake news. (newstarget.com)
  • First, a CDC document titled "Vaccine Excipient & Media Summary" lists all the vaccine excipient ingredients found in CDC-approved vaccines. (newstarget.com)
  • For the full list of excipients, see section 6.1.Stock Info Webcasts & Presentations. (cassefortisicure.it)
  • The most commonly used excipients are protectants, surfactants, buffers, and bulking agents, according to Alan Fites, a senior pharmaceutical scientist with Singota Solutions. (biopharminternational.com)
  • This webinar will provide an opportunity for attendees to gain a better understanding of commonly used excipients and their various functions in compounded preparations. (lp3network.com)
  • Medicines include an active pharmaceutical ingredient (API) as well as excipients, or the other ingredients that help the API do its work in the body. (usp.org)
  • Read about USP's work promoting quality of excipient ingredients. (usp.org)
  • Pharmaceutical excipients are substances that are added to the active pharmaceutical ingredients (prodrug) to enhance their stability, increase volume to ingestible levels, or facilitate delivery of drug in the body. (pharmiweb.com)
  • Polymers provide better shelf life and enable controlled/sustained release mechanisms for the active pharmaceutical ingredients and therefore have been mostly used as pharmaceutical excipients in a range of products. (pharmiweb.com)
  • Azelis, a leading global innovation service provider in the specialty chemicals and food ingredients industry, has been appointed as a distributor by DFE Pharma, a global leader in high-quality functional excipients for pharmaceuticals and nutraceuticals. (azelis.com)
  • Excipients, sometimes referred to as inactive or inert ingredients, are materials used every day in compounding and play a crucial role in the functionality and efficacy of many preparations. (lp3network.com)
  • Recognize the potential for excipient interactions with active drug(s) and other ingredients. (lp3network.com)
  • Recognize the relationship between excipients, active drug(s) and other ingredients. (lp3network.com)
  • Excipient - An excipient is an inactive substance used as a carrier for the active ingredients of a medication. (en-academic.com)
  • Excipients can either act as carriers (basis or vehicles) or diluents, etc., of the active ingredients or components. (nvronhealthcare.com)
  • Excipients and active ingredients form the major components of drugs. (nvronhealthcare.com)
  • As you can see from the screen shots of the document, below, the list of excipient ingredients is "current as of January 6, 2017," according to the CDC. (newstarget.com)
  • Excipients Included in U.S. Vaccines, by Vaccine" on the official website of the United States Centers for Disease Control and Prevention lists as ingredients cell lines cultured from aborted fetal cells. (asknoah.org)
  • Iris Ingredients is a leading importer and distributor of Pharmaceuticals Excipients. (cphi-online.com)
  • CordenPharma and Moderna extended a strategic manufacturing services agreement for the supply of lipid excipients to be used in Moderna's vaccine against SARS-CoV-2. (biopharminternational.com)
  • Excipients are the main components of controlled-release formulations. (grandviewresearch.com)
  • In aggregate, excipients manufactured in oral formulations produced nearly 57% of the market revenues in 2019, at a total figure of $3.9bn. (outsourcing-pharma.com)
  • However, the anticipated growth of the topical drug delivery ​ market worldwide, bolstered by multiple factors, is expected to push the excipients of topical formulations to surpass those of oral drug delivery methods. (outsourcing-pharma.com)
  • According to the report, the excipients market for topical formulations will be growing by 7.4% year-on-year during the forecast period. (outsourcing-pharma.com)
  • By regularly sharing analytical data on the level of nitrites in excipients, consortium members are able to use this supporting data and knowledge to assess the likelihood that a nitrate or nitrite will react to form a nitrosamine in formulations. (lhasalimited.org)
  • Our excipients provide efficient direct compression tableting procedures for nutraceutical and herbal formulations. (sigachi.com)
  • The pharmaceutical excipients market is projected to reach USD 11.5 Billion by 2027 from USD 8.6 Billion in 2022, at a CAGR of 5.9% during the forecast period. (bharatbook.com)
  • The global pharmaceutical excipients market size is expected to reach USD 14.2 Billion by 2030, with a CAGR of 5.39% from 2022 to 2030. (marketstatsnews.com)
  • A recent study by Precedence Research on the pharmaceutical excipients market offers a forecast for 2022 and 2030. (marketstatsnews.com)
  • The sustained release excipients market in North America has been expanding due to the adoption of sustained drug release techniques across the medical industry in the US and Canada. (tmrresearch.com)
  • The North America regional market is projected to dominate the global biologic excipients market, accounting for a maximum revenue share of the global market by 2017 end. (marketresearchblog.org)
  • The North America, Western Europe, and Asia Pacific markets accounted for 77.3% of the total biologic excipients market share in terms of value in 2017. (marketresearchblog.org)
  • Identify fundamental excipients in compounded preparations. (lp3network.com)
  • Classify excipients into functional groups related to compounded preparations. (lp3network.com)
  • In cosmetology , alginates extracted from Ascophyllum are used as emulsifiers and emulsion stabilizers in creams and lotions, as excipients absorbable by the epidermis, in preparations such as gels, creams, shampoos. (europa.eu)
  • Although many physicians use different IVIG preparations interchangeably and with similar overall efficacy, the individual products differ from each other in final purification steps, IgA content, and excipients. (medscape.com)
  • blended with a suitable excipient which is normally an inert substance. (researchgate.net)
  • However, as opposed to popular assumptions, excipients are not always inactive or inert and may result in side effects or adverse reactions if misused. (nvronhealthcare.com)
  • These excipients help in forming inert or non-reactive matrices that successively help in diffusing drugs at a slow pace. (tmrresearch.com)
  • Microcrystalline cellulose and gelatinized starch are currently the biggest sales and revenue-generating products for the pharmaceutical excipients market. (pharmiweb.com)
  • ACAM2000 is provided as a lyophilized preparation of purified live virus containing the following non-active excipients: 6-8 mM HEPES (pH 6.5-7.5), 2% human serum albumin USP, 0.5 - 0.7% sodium chloride USP, 5% mannitol USP, and trace amounts of neomycin and polymyxin B. (newstarget.com)
  • Croscarmellose sodium (medicinal excipients) is a cross-linked, partially carboxymethylated sodium salt of cellulose, or a cross-linked polymer of sodium carboxymethyl cellulose. (bioherbkey.com)
  • Other manufacturers, in an effort to keep costs down, dilute their products with cheap fillers and excipients, which cheats you out of the active ingredient and contaminates your product with unneeded chemicals. (greenorganicsupplements.com)
  • Factors for assessing excipient variability, the associated challenges developers need to address to design and manufacture solid oral drug products, and solutions for such challenges are examined. (pharmtech.com)
  • Well, excipients used within the pharmaceutical drug products are diverse in terms of their chemistry, origin, manufacture, and also control. (pharmtech.com)
  • Indeed, between the multiple manufacturers of an excipient, it is likely there will be differences in the raw materials and the production process used, the scale of manufacture, and location, all which can contribute to the variability of an excipient product's physicochemical properties. (pharmtech.com)
  • Among the segments of the pharmaceutical excipients market, the manufacture of organic chemicals produced revenues of $5.8bn in 2019, accounting for 80% of the market. (outsourcing-pharma.com)
  • The word excipient, derived from the Latin phrase excipere - to receive, to except, or take out, refers to any component other than the active pharmaceutical ingredient contained in solid dosage forms or used to manufacture a finished pharmaceutical product (FPP). (nvronhealthcare.com)
  • Excipient - Un excipient désigne toute substance autre que le principe actif dans un médicament, un cosmétique ou un aliment. (en-academic.com)
  • excipient - [ɛk sɪpɪənt] noun an inactive substance that serves as the vehicle or medium for a drug or other active substance. (en-academic.com)
  • Within 20 years, peanut oil was the preferred "excipient" - meaning a substance formulated alongside the active ingredient of a medication for the purpose of long-term stabilization. (yogaesoteric.net)
  • Just as Pirkle does not break in this region of the drug substance imuran and excipients. (goldgreiner.de)
  • These excipients are most critical to the structure and ultimately the function of freeze-dried biologic drug products. (biopharminternational.com)
  • Managing excipient variability is an essential element in designing and manufacturing robust solid oral drug products and is an integral task in when applying quality-by-design (QbD) principles. (pharmtech.com)
  • With an increasing focus on QbD, both innovator and generic-drug developers will be required to demonstrate excipient risk management in relation to the drug products' critical quality attributes. (pharmtech.com)
  • Broadly speaking, we could consider two classes of excipient products. (pharmtech.com)
  • The natural or naturally derived excipient products and factors, including the crop source along with environmental variables, such as the growing and processing conditions, can all affect the physicochemical properties of the resultant excipient product. (pharmtech.com)
  • Excipient choice and the maintenance of exceptionally high standards of performance in use are absolutely key to the success of most modern pharmaceutical products. (sgs-latam.com)
  • This review article discusses the advantages of co-processing, the need of co-processed excipient, general steps in developing co-processed excipient, limitation of co-processed excipient, technologies used in developing co-processing excipients, co-processed excipients in the literature, marketed products and future trends. (who.int)
  • FDA also set a limit on 1,4-dioxane at 10 ppm in approving glycerides and polyglycerides for use as excipients in products such as dietary supplements (FDA 2006). (cdc.gov)
  • The growth of polymers in the pharmaceutical excipients market is expected to rise for all forms of administrations like liquids, tablets, and capsules during the projected period. (pharmiweb.com)
  • Polymers biologic excipients are anticipated to lead the biologic excipients market over the forecast period. (marketresearchblog.org)
  • Excipients not only affect the stability of proteins and other biologics, they also determine the appropriate operating parameters for the lyophilization process. (biopharminternational.com)
  • The researchers found the excipient delivered improved performance in liquid stabilisation of protein biologics, providing a mechanistic understanding of the key causes and drivers of protein aggregation. (manufacturingchemist.com)
  • Please enter function of excipients, e.g. sweetener, preservative, thickening agent, etc. which can be selected from the drop-down list. (npra.gov.my)
  • Regularly updated on MedicinesComplete, Pharmaceutical Excipients provides information on the characteristics and physical properties of excipients, including side effects, monographs which are thoroughly indexed for selecting excipients and support for research and knowledge. (medicinescomplete.com)
  • Because the conditions during freezing and drying are different, the stresses on biologic drug substances are different, and combinations of excipients are often required to provide the protection and stabilization required for a given protein, monoclonal antibody, etc. (biopharminternational.com)
  • Because they comprise up to 90% of medications, the quality of excipients is critical for a drug to be safe and effective. (usp.org)
  • Fourier Transform Infra Red Spectroscopy (FTIR) and Differential Scanning Calorimetry (DSC) were used to study the possible drug - excipient interaction. (researchgate.net)
  • Understanding the effects of normal excipient variability is important to ensure that potential risks to drug-product quality are effectively managed. (pharmtech.com)
  • Often, knowledge and tools to proactively assess the effects of excipient variability upon drug-product quality are available. (pharmtech.com)
  • Expirations of drug patents in European countries, which open the road for generics manufacturing, such as in the case of Pfizer's blockbuster Lyrica ​, have led the European Union (EU) market to account for the largest share of the global pharmaceutical excipients market. (outsourcing-pharma.com)
  • How do we make sure that the drug, or more specifically its added excipients, does not affect the delivery system's performance? (westpharma.com)
  • It can also enable an easier transition from vial system to PFS, since knowing whether or not a drug requires an excipient which is incompatible with, for example, silicone oil, will enable decisions on what type of syringe to use. (westpharma.com)
  • The growth can be attributed to the expanding pharmaceutical industry which has fueled the drug production thereby increasing consumption rate for excipients. (bharatbook.com)
  • Along with this new age, nanoparticle-based excipients are being developed to support nano-drug delivery methods. (pharmiweb.com)
  • The large number of advantages served by controlled drug release has created tremendous growth opportunities within the global sustained release excipients market. (tmrresearch.com)
  • The ability of sustained drug release to relieve patients of pain has created tremendous demand within the global market for sustained release excipients in recent times. (tmrresearch.com)
  • Furthermore, the advantages served by sustained drug release over conventional drugs are also expected to give an impetus to the growth of the global sustained release excipients market. (tmrresearch.com)
  • A key trend witnessed in the biologic excipients market is increasing adoption of continuous processing of biologic excipients, dependence of large drug manufacturers on in-house biologic excipients production, vast proportion of imported excipients leading to production delays, and regulatory harmonisation with respect to gradation of excipients. (marketresearchblog.org)
  • DRIFTS also may be used alphamox to investigate drug-excipient compatibility. (goldgreiner.de)
  • I am thrilled to start this new project, which aims to (i) quantify the presence of excipients in drugs available on the French market, (ii) estimate the French population exposure to these excipients through drug consumption, and (iii) investigate the potential relationship between titanium dioxide exposure from drugs and cancer risk. (who.int)
  • It is one of the few excipients available to improve viral stability for vaccines and gene therapies. (invitria.com)
  • Additionally, factors like functional excipients development and upsurge in generics market is also likely to propel market growth. (bharatbook.com)
  • For an individual manufacturer of an excipient product, there may be lot-to-lot variability of the physicochemical properties. (pharmtech.com)
  • Thus, physicochemical excipient-container interactions in prefilled syringes need to be understood to have a holistic view of their impact on syringe functionality. (westpharma.com)
  • There is no single-component excipient fulfills all the requisite performance to allow an active pharmaceutical ingredient to be formulated into a specific dosage form. (who.int)
  • Do not administer in case of hypersensitivity to the active substances or any of the excipients. (mybudgetpetstore.com)
  • Currently the largest data sharing consortium that Lhasa hosts, the Nitrites in Excipients database has seen significant growth since it's inception less than 2 years ago. (lhasalimited.org)
  • Some of the major factors contributing to the growth of the Asia Pacific market are low-cost manufacturing advantage, increasing per capita income, and low regulatory stringency that support the growth of the pharmaceutical excipients market in the region. (bharatbook.com)
  • In contrast, the market growth could substantially be hampered by tight rules and regulations regarding the negative environmental impacts of pharmaceutical excipients. (pharmiweb.com)
  • Moreover, the emergence of several stakeholders, angel investors, and venture capitalists who are willing to invest in the global sustained release excipients market has also given an impetus to the growth of this market. (tmrresearch.com)
  • A report on the global sustained release excipients market explains a multitude of factors that have contributed towards market growth in recent times. (tmrresearch.com)
  • The report is an inside account of the dynamics and forces that have played a defining role in the growth of the global sustained release excipients market. (tmrresearch.com)
  • The rise in the incidence of infectious and chronic diseases across the world has played a major role in the growth of the global sustained release excipients market. (tmrresearch.com)
  • Polymer biologic excipients account for the highest revenue share and are anticipated to witness a growth rate of 3.7% over the forecast period. (marketresearchblog.org)
  • The study analyzes crucial trends that are currently determining the growth of the pharmaceutical excipients market. (marketstatsnews.com)
  • Analysis of major countries, which hold growth opportunities or account for significant share has also been included as part of geographic analysis of the pharmaceutical excipients market. (marketstatsnews.com)
  • s adjective Etymology: Latin excipient , excipiens, present participle of excipere to take out, make an exception of, take, receive more at except : taking exception II. (en-academic.com)
  • Even for synthetic or semisynthetic excipient, differences in the feedstock, such as the organic and inorganic components from crude oil or gas, along with variability in chemical processing, will all contribute to the overall variability of the excipient product itself. (pharmtech.com)
  • Exbumin has been approved for use as an excipient in injectable therapeutics by regulatory agencies. (invitria.com)
  • In this article, Robertson offers insight on managing excipient variability in a QbD paradigm. (pharmtech.com)
  • Theoretical calculations based on Hansen Solubility Parameters (HSP) can provide insight into how much an excipient will interact with delivery system materials such as silicone oil. (westpharma.com)
  • Multidose vials used for injection, Excipients: Benzyl alcohol and H 2 O. (cdc.gov)
  • Excipient selection strongly influences lyophilization performance for biologic drugs. (biopharminternational.com)
  • In terms of revenue, the global biologic excipients market is projected to register a CAGR of 3.6% over the forecast period owing to various factors, regarding which FMI offers detailed insights and forecasts in this report. (marketresearchblog.org)
  • Biopharmaceutical manufacturers is the leading segment in the global biologic excipients market over the forecast period. (marketresearchblog.org)
  • Some of the key players featured in this report on the global biologic excipients market include BASF Corporation, FMC Corporation, Wacker Chemie AG, Evonik Industries AG, Ashland Global Holdings Inc., Archer-Daniels-Midland Co., Roquette Freres S.A., The Dow Chemical Company, Colorcon Inc., Signet Chemical Co. Pvt. (marketresearchblog.org)
  • Métodos: ensayo clínico aleatorizado, doble ciego, https://orcid.org/0000-0003-4003-1365 realizado con personas con diabetes tipo 2, en unidades de atención primaria de salud. (bvsalud.org)
  • However, excipients make up the bulk of drugs and medicines, making about 90% of each drug's composition. (nvronhealthcare.com)
  • Sustained dosing of drugs holds immense significance for a range of industries, and hence, the use of sustained release excipients has become more pronounced in recent times. (tmrresearch.com)
  • Excipients for modified release help in releasing drugs at a slow pace over an extended time period, and this helps in avoiding dose-dumping. (tmrresearch.com)
  • The dynamics of the market for sustained release excipients can be explained more deftly through an analysis of the aforementioned segments. (tmrresearch.com)
  • Besides this, the regional dynamics of the global sustained release excipients market have also been included in the report. (tmrresearch.com)
  • This report explicates on vital dynamics such as the drivers, restraints, and opportunities for key market players, along with key stakeholders as well as emerging players associated with the manufacturing of pharmaceutical excipients. (marketstatsnews.com)
  • The study also provides the dynamics that are responsible for influencing the future status of the pharmaceutical excipients market over the forecast period. (marketstatsnews.com)
  • We are into partnership with several renowned principals from across the globe to supply high quality Pharmaceuticals Excipients across India. (cphi-online.com)
  • Hence, the demand for sustained release excipients in the healthcare sector is expected to keep escalating in the years to come. (tmrresearch.com)
  • Excipient World is the leading education, networking and sourcing resource for the $6+ billion and growing global excipient market. (ashland.com)
  • Bolstered by manufacturing advancements, the global revenues of the pharmaceutical excipients market are expected to grow at a CAGR of 5.8% in the coming years. (outsourcing-pharma.com)
  • In 2019, the pharmaceutical excipients market is worth $6.97bn (€6.28bn), with its revenues expected to reach $9.79bn (€8.82bn) by 2025, according to research ​ conducted by Markets and Markets. (outsourcing-pharma.com)
  • This report provides a detailed picture of the pharmaceutical excipients market. (bharatbook.com)
  • The demand within the global sustained release excipients market has been rising on account of key improvements in the pharmaceutical industry. (tmrresearch.com)
  • The global sustained release excipients market may be segmented on the basis of the following parameters: product, route of administration, technology, and region. (tmrresearch.com)
  • The global sustained release excipients market is projected to keep expanding over the forthcoming years. (tmrresearch.com)
  • The market for sustained release excipients in Asia Pacific has been expanding on account of the growing population across China and India. (tmrresearch.com)
  • Some of the key players in the global sustained release excipients market are Depomed, Inc. (tmrresearch.com)
  • The global market is segmented based on excipient type, end user and region. (marketresearchblog.org)
  • A detailed assessment of the pharmaceutical excipients market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. (marketstatsnews.com)
  • A list of prominent companies operating in the pharmaceutical excipients market along with their product portfolio enhances the reliability of this comprehensive research study. (marketstatsnews.com)
  • The report provides in-depth segment analysis of the global pharmaceutical excipients market, thereby providing valuable insights at macro as well as micro levels. (marketstatsnews.com)